<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel xmlns:cfi="http://www.microsoft.com/schemas/rss/core/2005/internal" cfi:lastdownloaderror="None">
<title cf:type="text"><![CDATA[International Journal of Ophthalmology Press -->Brief Report]]></title>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual outcome after phacoemulsification with IOL
implantation in patients with anterior lenticonus due
to Alport syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To describe visual improvement after phacoemulsification
with intraocular lens (IOL) implantation in 7 eyes with
anterior lenticonus(ALC) secondary to Alport syndrome（AS）.
·METHODS: Seven eyes from 4 patients with AS underwent
phacoemulsification with IOL implantation due to ALC
·RESULTS: All the patients resumed excellent visual acuity
after surgery.
·CONCLUSION: We recommend the phacoemulsification
with IOL implantation as a safe procedure in ALC due to AS.]]></description>
<pubDate></pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Mohammad Ali Zare,Mohammad Taher Rajabi,Syed Jafar Oskouee and Mohammad Nili]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Ali Zare,Mohammad Taher Rajabi,Syed Jafar Oskouee and Mohammad Nili</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801021]]></guid><cfi:id>125</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[New modified iris suture technique for pupillary dilation in aphakic eyes during vitreoretinal surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To describe a modified simple iris suture for pupillary dilation technique during vitrectomy in cases with a miotic pupil. Four translimbal incisions were created with a sharp straight blade at 1:30, 10:30, 4:30, and 7:30 o'clock, respectively. The straight needle of 10-0 polypropylene suture and a Sinskey IOL hook was used to displace the pupillary margin toward the limbus. In 3 cases, four sutures caused a 6-mm to 9-mm square-shaped pupil, and the pupil was allowed to return to a smaller size at the end of the operation. It is simple and may reduce postoperative complications.]]></description>
<pubDate></pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Feng-Mei Han,Quan-Hong Han and Yan-Hua Chu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Feng-Mei Han,Quan-Hong Han and Yan-Hua Chu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004019]]></guid><cfi:id>124</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of amnion membrane transplantation on corneal neovascularization in 10 patients with alkali burn  ]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101025]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[By observing clinical cases, we studied the curative effect of amnion membrane transplantation on decreasing corneal neovascularization (CNV). It was a non-randomized retrospective case-control study. Among 17 cases (21 eyes) of third-degree alkali burns from 2007 to 2010, 10 cases (12 eyes) were performed with amnion membrane transplantation operation, and others were not. Amnion membrane transplantation was performed at the 3rd day after burn in the treatment group. Areas of CNV in double groups were measured at the 14th day and 60th day after burn. Area of CNV in the treatment group was (66.207±7.251)mm2 at the 14th day after burn, and was 18.27% lower than that in the control group. Area of CNV in the treatment group was (120.046±13.812)mm2 at the 60th day after burn, and was 11.35% lower than that in the control group. There was both statistical significance (P<0.05). Amnion membrane transplantation operation can inhibit the growth of corneal neovascularization induced by alkali burn.]]></description>
<pubDate></pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Lan Yin and Yu-Li Pi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lan Yin and Yu-Li Pi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101025]]></guid><cfi:id>123</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of optic disc damage by optical coherence tomography in terms of therapy in non-arteritic anterior ischemic optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160920]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study aimed to assess the relationship between the rate of nerve fiber loss in non-arteritic anterior ischemic optic neuropathy (NAION) and time delay before therapy. Total 24 patients received the same treatment within or after 2wk (early and late groups). There were significantly lower level of destruction of nerve fibers (P=0.0014) and significantly better visual field sensitivity (P=0.039) in early group. The results indicate that therapy should be started within 2wk. The degree of ischemic damage due to NAION correlates well with retinal nerve fiber layer thickness and the ischemia-induced decrease in visual field sensitivity.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Zsuzsa Balogh, Márta Kasza, Julianna Várdai, Izabella Reznek, Judit Damjanovich, Adrienne Csutak, András Berta and Valéria Nagy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zsuzsa Balogh, Márta Kasza, Julianna Várdai, Izabella Reznek, Judit Damjanovich, Adrienne Csutak, András Berta and Valéria Nagy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160920]]></guid><cfi:id>122</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Inverted internal limiting membrane flap technique for very large macular hole]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160822]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the anatomical and visual outcome of idiopathic macular holes greater than 1000 μm using the inverted internal limiting membrane flap technique.
METHODS: This retrospective case series included 5 eyes of 5 patients with idiopathic macular hole with base diameter greater than 1000 μm who underwent inverted internal limiting membrane flap technique along with standard 23G pars plans vitrectomy with posterior hyaloid detachment and fluid gas exchange with 12%-14% perfluoropropane (C3F8). Preoperative and postoperative visual acuity and spectral domain optical coherence tomography images were evaluated. The main outcome measures were visual outcome and macular hole closure.
RESULTS: Mean age was 63.2±8.4y with all 5 subjects being females. Mean duration of symptoms was 11±14mo with a mean postoperative follow up of 13.2±13mo. The mean base diameter of the macular holes was 1420±84.8 μm (1280-1480 μm). Type 1 closure was achieved in four out of five patients, while one patient had type 2 closure using the inverted internal limiting membrane (ILM) flap technique. Median baseline BCVA was 0.79 logMAR (Snellen’s equivalent 20/120) and median final BCVA 0.6 logMAR (Snellen’s equivalent 20/80) with mean visual improvement of approximately three lines improvement. No complications related to surgical procedure were noted.
CONCLUSION: The inverted internal limiting membrane flap technique may be promising for very large macular holes with high rate of macular closure and good visual outcome.]]></description>
<pubDate>2016/8/15 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Mitali Khodani, Pooja Bansal, Raja Narayanan and Jay Chhablani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mitali Khodani, Pooja Bansal, Raja Narayanan and Jay Chhablani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160822]]></guid><cfi:id>121</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Descemet’s membrane detachments post cataract surgery: a management paradigm]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161223]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Descemet’s membrane detachments (DMD) are relatively common after cataract surgery and most do not require any treatment. However, if large DMD are not treated appropriately, significant visual morbidity can ensue. We aim to develop a guideline for the management of DMD post cataract surgery based on a retrospective review of all cases encountered at the Royal Victorian Eye and Ear Hospital, Melbourne, Australia over a 4-year period from 2010 to 2014. We suggest conservative management if the visual axis is not involved; however, after 3mo surgical intervention may be warranted to prevent corneal sequelae. In cases where the visual axis is involved we suggest early intervention with air tamponade. The main risk factor for irreversible corneal oedema and subsequent endothelial transplant appears to be direct endothelial trauma rather than the DMD itself.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Chameen Samarawickrama, Jacqueline Beltz and Elsie Chan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chameen Samarawickrama, Jacqueline Beltz and Elsie Chan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161223]]></guid><cfi:id>120</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Decreased paraoxonase1 activity and increased malondialdehyde and oxidative DNA damage levels in primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161024]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To investigate the malondialdehyde (MDA) levels, paraoxonase1 (PON1) activity and 8-hydroxy 2-deoxyguanosine (8-OHdG) levels in the primary open angle glaucoma (POAG) patient. Blood samples from 52 healthy individuals and 53 patients with POAG were analyzed for MDA and 8-OHdG by HPLC (high-performance liquid chromatography) and PON1 by spectrophotometry. The data obtained were analyzed statistically. MDA levels were 10.46±8.4 and 4.70±1.79 μmol; PON1 levels were 121±39.55 and 161.62±60.22 U/mL; and 8-OHdG values were 1.32±0.53/106 dG and 0.47±0.27/106 dG in the POAG patients and the control group, respectively. The difference was significant in MDA levels, 8-OHdG levels and PON1 activity in POAG patients in comparison with controls (P<0.001). We concluded that the observed increase in MDA and 8-OHdG levels may be correlated with decreased PON1 activity. Oxidative stress plays an important role in glaucoma development.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ugur Yilmaz Mumcu, Ibrahim Kocer, Orhan Ates and H. Hakan Alp]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ugur Yilmaz Mumcu, Ibrahim Kocer, Orhan Ates and H. Hakan Alp</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161024]]></guid><cfi:id>119</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of open ultraviolet germicidal irradiation lamps on functionality of excimer lasers used in cornea surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170922]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We report on the impact of direct ultraviolet germicidal irradiation (UVGI) on reflective optics, used in the excimer laser system Allegretto Eye-Q. The aim of our work was to confirm our hypothesis based on long-rate observations of obtained anomalies in post-operative results that are attributed to degradation of reflective optics upon ultraviolet radiation. The presence of direct UVGI coupled with humidity in the operating environment caused merging anomalies and unwanted post-operative correction values. Ultraviolet-A radiation caused a similar effect on the reflective cover of the mirrors.]]></description>
<pubDate>2017/9/5 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jaroslavas Belovickis, Aliaksei Kurylenka and Vadim Murashko]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jaroslavas Belovickis, Aliaksei Kurylenka and Vadim Murashko</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170922]]></guid><cfi:id>118</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Organ transplantation scandal influencing corneal donation rate]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170625]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[In the majority of countries, there is a shortage of donor corneas for corneal transplantations. This study investigated the impact of organ transplantation scandals on corneal donation rate at the University Hospital Tübingen. Each deceased patient was considered as a potential corneal donor. An ophthalmic resident handled with stable methods of procedures the corneal donor procurement from 2009 to 2015. The rates of corneal donation were examined and analyzed. Among the 5712 hospital deaths, consent for corneal donation was obtained in 711 cases. The mean annual corneal donation rate was 12.4%. Since 2009, the donation rate per year could be increased with exception of 2013 and 2015. In the end of 2012 and 2014 two huge organ donation scandals were known in Germany. In the following years 2013 and 2015 corneal donation rate decreased significantly (P=0.0181 and P=0.0006). We concluded that transplantation scandals have a significant impact on corneal donation rate. Improving professional's performance through full transparency and honesty is very important to earn trust of potential donors and their families.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Tobias R&ouml;ck, Matthias Bramkamp, Karl Ulrich Bartz-Schmidt and Daniel R&ouml;ck]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tobias R&ouml;ck, Matthias Bramkamp, Karl Ulrich Bartz-Schmidt and Daniel R&ouml;ck</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170625]]></guid><cfi:id>117</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of surgically induced astigmatism among different surgeons performing the same incision]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170626]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To compare surgically induced astigmatism (SIA) of different surgeons, who perform the same main incision. Two hundred and seventy eyes underwent cataract surgery with phacoemulsification by four different surgeons (A, B, C, and D). A 3-step, 3.0 mm, superotemporal for the right eye and superonasal for the left eye clear corneal incision was performed. A comparison in SIA among A, B, C and D surgeon was made. No significant difference was found in SIA at both first and sixth postoperative month between different surgeons (P>0.05). SIA is more dependent on incisional characteristics and preoperative astigmatism and less on the surgeon.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Sofia Theodoulidou,Ioannis Asproudis,Aristidis Athanasiadis,Michael Kokkinos and Miltiadis Aspiotis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sofia Theodoulidou,Ioannis Asproudis,Aristidis Athanasiadis,Michael Kokkinos and Miltiadis Aspiotis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170626]]></guid><cfi:id>116</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment of myopic foveoschisis via macular buckling and vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170526]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The aim of the present study was to evaluate the efficacy and safety of the treatment of myopic foveoschisis patients using the macular buckling with L-shaped titanium plate and silicon sponge combined with vitrectomy. The data of the patients who underwent macular buckling combined with vitrectomy was collected. The study recorded the following parameters: best corrected visual acuity (BCVA), axial length, intraocular pressure, central macular thickness, and the position of the titanium plate. Following the surgery, the BCVA of the included patients were improved, whereas the axial lengths were reduced followed by resolution of the foveoschisis compared with that noted prior to the operations. All patients had orbital CT examination and the results indicated that the titanium plates were appropriately placed and were not in contact with the optic nerve. Therefore, it is effective to treat myopic foveaschisis by macular buckling using the L-shaped titanium plate and silicon sponge in the presence of vitrectomy.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Si-Qi Xiong,Hai-Bo Jiang,Fang-Ling Li,Yan-Xiu Li,Jie Yang,Xiao-Bo Xia and Hui-Zhuo Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Si-Qi Xiong,Hai-Bo Jiang,Fang-Ling Li,Yan-Xiu Li,Jie Yang,Xiao-Bo Xia and Hui-Zhuo Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170526]]></guid><cfi:id>115</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcomes at one year following keratoconus treatment with accelerated transepithelial cross-linking]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170424]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study evaluated the clinical outcomes in keratoconus corneas following accelerated transepithelial corneal collagen cross-linking (CXL) (Avedro KXL&reg; system, Waltham, MA, USA) over one year of follow-up. The mean depth of the demarcation line measured by optical coherence tomography (OCT) was 205.19 &micro;m. One month after surgery, a non-statistically significant change was noted in sphere (P=0.18) and in spherical equivalent (P=0.17), whereas a significant improvement was observed in corrected distance visual acuity (P=0.04). A significant change was observed in topographic astigmatism (P=0.03) and posterior corneal a sphericity (P=0.04). Accelerated transepithelial CXL may be a useful technique for the management of progressive keratoconus.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Alberto Artola, David P. Pi&ntilde;ero, Pedro Ruiz-Fortes, Roberto Soto-Negro and Rafael J Pérez-Cambrodí]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alberto Artola, David P. Pi&ntilde;ero, Pedro Ruiz-Fortes, Roberto Soto-Negro and Rafael J Pérez-Cambrodí</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170424]]></guid><cfi:id>114</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Enhanced depth OCT imaging of the lamina cribrosa for 24 hours]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170220]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The lamina cribrosa thickness (LCT) could be affected by dynamic changes in its structure. Using Spectral-domain-optical coherence tomography (SD-OCT), we have studied the behaviour of the laminar region in 14 young subjects over 24h. Significant changes in LCT were observed, depending on the time at which the measurement was taken, with the maximum thickness being observed at 7.30 p.m., and the minimum at 7.30 a.m. This finding could suggests a circadian pattern in the LCT thickness in healthy subjects, which could have implications for the classification, diagnosis and prognosis of both normal and glaucomatous subjects.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Pedro Naranjo Bonilla, Rafael Giménez Gómez, David Ríos Jiménez, María Luísa Varas Fabra, María del Carmen Mu&ntilde;oz Villanueva, Rocío García Catalán, Pilar Font Ugalde, María Soledad Poblador Fernández, José Luís Lancho Alonso and José María Gallardo Galera]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pedro Naranjo Bonilla, Rafael Giménez Gómez, David Ríos Jiménez, María Luísa Varas Fabra, María del Carmen Mu&ntilde;oz Villanueva, Rocío García Catalán, Pilar Font Ugalde, María Soledad Poblador Fernández, José Luís Lancho Alonso and José María Gallardo Galera</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170220]]></guid><cfi:id>113</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Our experience with smartphone and spherical lens for the eye fundus examination during humanitarian project in Africa]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170125]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To present the experience of eye fundus photo documentation by using the plus 20 diopters spherical Volk lens and a smartphone with 4.2 Mpix camera and LED flash within the screening project of eye disorders in countries where the standard ophthalmology equipment is not available. Totally 241 patients underwent ophthalmology screening examination. The documentation of the eye fundus included patients with Burkitt lymphoma, Kala Azar, malnutrition with unknown etiology, tuberculosis, HIV positive patients, Usher syndrome and hypertension. This technique as an alternative way of screening will become a standard within examination of patients with eye disorders in outfield regions of developing countries.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Alena Furdova, Adriana Furdova and Vladimir Krcmery]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alena Furdova, Adriana Furdova and Vladimir Krcmery</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170125]]></guid><cfi:id>112</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trans-epithelial accelerated corneal cross-linking for keratoconus in children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171220]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The aim of the study is to evaluate the safety and efficacy of trans-epithelial accelerated corneal cross-linking (TE-ACXL) in children with progressive keratoconus. Retrospective, case-series of 23 eyes of 14 children who underwent TE-ACXL. Evaluations were performed at baseline and 1, 3, 6, 12 and 18mo postoperatively. Mean follow-up time of 23.82±3.15mo and mean age was 13.7±1.4y (range 11 to 16y). Mean preoperative uncorrected distance visual acuity changed from 0.92±0.45 logMAR (20/160) to 0.71±0.40 logMAR (20/100) (P=0.001). Mean keratometry (Km) changed from 53.87± 6.03 to 53.00±5.81 (P=0.001). Pachymetry did not have significant changes at last follow-up (P=0.30). The mean preoperative sphere was -5.58±2.48 and -4.89±4.66 D (P=0.11) at last follow-up; refractive cylinder from -5.58±2.48 to -5.02±2.23 (P=0.046). In conclusion, tomographic and refractive stability are shown in over 91% of eyes with pediatric progressive keratoconus who underwent TE-ACXL.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Andrew Olivo-Payne, Juan Carlos Serna-Ojeda, Erick Hernandez-Bogantes, Alexandra Abdala-Figuerola, Lucero Pedro-Aguilar, Alejandro Lichtinger, Arturo Ramirez-Miranda, Alejandro Navas and Enrique O. Graue-Hernandez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Andrew Olivo-Payne, Juan Carlos Serna-Ojeda, Erick Hernandez-Bogantes, Alexandra Abdala-Figuerola, Lucero Pedro-Aguilar, Alejandro Lichtinger, Arturo Ramirez-Miranda, Alejandro Navas and Enrique O. Graue-Hernandez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171220]]></guid><cfi:id>111</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ultrasound reliability in detection of retinal tear in acute symptomatic posterior vitreous detachment with vitreous hemorrhage]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171221]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Cross-sectional study of 75 consecutive patients presenting with acute symptomatic posterior vitreous detachment (ASPVD) and vitreous hemorrhage was conducted at University Eye Clinic, University Hospital “Sveti Duh”, Zagreb, Croatia. To check ultrasound reliability in detecting retinal tears in patients with ASPVD, transpalpebral ultrasound of the eye and the orbit was performed followed by fundus examination initially and in 6wk period. In 13 (17%) patients membranous lesion with ultrasound characteristics of retinal tear was detected. Ophthalmoscopy confirmed the diagnosis in 8/13 patients. In 62/75 patients neither ultrasound nor clinical examination revealed retinal tear. Sensitivity of ultrasound examination was 100%, specificity 92%, positive predictive value 62% and negative predictive value 100%. Ultrasound proved to be a reliable and accurate method for detection of retinal tears in ASPVD. Given the high sensitivity and negative predictive value, negative result on B-scan ultrasound excludes the probability of the retinal tear with a high degree of certainty.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Biljana Kuzmanovi&#263; Elabjer, Mladen Bu&#353;i&#263;, Ana Bi&#353;&#263;an Tvrdi, Daliborka Mileti&#263;, Damir Bosnar and Mirjana Bjelo&#353;]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Biljana Kuzmanovi&#263; Elabjer, Mladen Bu&#353;i&#263;, Ana Bi&#353;&#263;an Tvrdi, Daliborka Mileti&#263;, Damir Bosnar and Mirjana Bjelo&#353;</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171221]]></guid><cfi:id>110</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171222]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[A retrospective analysis was performed of patients who received a paracentesis immediately following an intravitreal injection of bevacizumab or triamcinolone acetonide. These patients were previously diagnosed as having glaucoma, ocular hypertension, or had responded previously with sustained elevated intraocular pressure. Of 1661 procedures were performed. Totally 219 (13%) of the injections were on phakic patients. A median (SD) of 210 μL (40 μL) of aqueous was removed during each paracentesis. There were no reported incidences of any complications. We propose performing a paracentesis immediately following intravitreal injections for patients at risk for ocular hypertension, glaucoma, and retinal vein or artery occlusion.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Austin Bach, Artur Filipowicz, Aaron S. Gold, Azeema Latiff and Timothy G. Murray]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Austin Bach, Artur Filipowicz, Aaron S. Gold, Azeema Latiff and Timothy G. Murray</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171222]]></guid><cfi:id>109</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of surgical outcome of trabeculectomy and phacotrabeculectomy in Chinese glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171223]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Our study retrospectively reviewed the surgical outcomes up to 3mo of 38 consecutive Chinese glaucoma patients who underwent trabeculectomy (n=18) or phacotrabeculectomy (n=20). Baseline age, visual acuity, and intraocular pressure were comparable. Intraocular pressure from post-operative 1d to 3mo were similar between 2 groups. Complete success was achieved in 65% of phacotrabeculectomy, and 66.7% of trabeculectomy cases; while failure occurred in 16.7% of phacotrabeculectomy, and 10% of trabeculectomy cases at 3mo. Phacotrabeculectomy group consistently showed better improvement in visual acuity. Diffuse blebs occurred in 65% of phacotrabeculectomy and 83% of trabeculectomy eyes; and flat blebs in 35% of phacotrabeculectomy, but none after trabeculectomy. There was more hypotony (5% vs 0) after phacotrabeculectomy. To conclude, phacotrabeculectomy and trabeculectomy demonstrated comparable intraocular pressure control up to 3mo post-operatively. However, phacotrabeculectomy patients had better visual acuity improvement. Nonetheless, more diffuse bleb and less hypotony were present following trabeculectomy.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Bonnie Nga Kwan Choy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bonnie Nga Kwan Choy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171223]]></guid><cfi:id>108</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new interpretation and quantitative method for diplopia test: 304 cases of ocular motor nerve palsy for clinical test and verify]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171120]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We introduce a new interpretation and quantitative method for computerized diplopia test. By comparing this new method to the Hess screen test, we validate its applicability among 304 patients with ocular motor nerve palsy. This new method shows great assistant value as the Hess screen test in making accurate diagnosis and quantitative evaluation the severity of diplopia. Furthermore, it is more convenient and suitable for daily clinical use.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ling-Yun Zhou, Tie-Juan Liu, Xue-Mei Li, Chang Su, Xiao-Jie Ji and Ming Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ling-Yun Zhou, Tie-Juan Liu, Xue-Mei Li, Chang Su, Xiao-Jie Ji and Ming Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171120]]></guid><cfi:id>107</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The prevalence of uncorrected refractive error in urban, suburban, exurban and rural primary school children in Indonesian population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171121]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Uncorrected refractive error (URE) is a major health problem among school children. This study was aimed to determine the frequency and patterns of URE across 4 gradients of residential densities (urban, exurban, suburban and rural). This was a cross-sectional study of school children from 3 districts in Yogyakarta and 1 district near Yogyakarta, Indonesia. The information regarding age, sex, school and school grader were recorded. The Snellen’s chart was used to measure the visual acuity and to perform the subjective refraction. The district was then divided into urban, suburban, exurban and rural area based on their location and population. In total, 410 school children were included in the analyses (urban=79, exurban=73, suburban=160 and rural=98 school children). Urban school children revealed the worst visual acuity (P<0.001) and it was significant when compared with exurban and rural. The proportion of URE among urban, suburban, exurban and rural area were 10.1%, 12.3%, 3.8%, and 1%, respectively, and it was significant when compared to the proportion of ametropia and corrected refractive error across residential densities (P=0.003). The risk of URE development in urban, suburban, exurban, and rural were 2.218 (95%CI: 0.914-5.385), 3.019 (95%CI: 1.266-7.197), 0.502 (95%CI: 0.195-1.293), and 0.130 (95%CI:0.017-0.972), respectively. Urban school children showed the worst visual acuity. The school children in urban and suburban residential area had 2 and 3 times higher risk of developing the URE.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Indra Tri Mahayana, Sagung Gede Indrawati and Suhardjo Pawiroranu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Indra Tri Mahayana, Sagung Gede Indrawati and Suhardjo Pawiroranu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171121]]></guid><cfi:id>106</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The use of choline in association with the Bangerter filters for the treatment of amblyopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171122]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The study investigated the effects of choline combined with Bangerter filter in the treatment of amblyopia. All amblyopic subjects used a Bangerter filter on the corrective spectacle lens (1d over the left eye, 1d over the right eye). Choline was then administered orally to 39 patients once daily, five days per week for the entire study period. Subjects treated with the Bangerter filter showed a mean visual acuity of 0.27 logMAR; at 12mo of treatment, the mean visual acuity reached 0.09 logMAR. Patients treated with the Bangerter filter and citicoline showed a mean visual acuity of 0.35 logMAR; at 12mo of treatment, the mean visual acuity reached 0.01 logMAR. No significant changes in the angle of deviation were observed in both groups. Subjects in both forms of amblyopia therapies demonstrated an increase in visual acuity. However, these effects were markedly enhanced when coupled with the administration of choline. Findings suggest that the effects are particularly relevant in the more severe amblyopic cases.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Lelio Sabetti, Francesco Masedu, Chiara Tresca, Federica Bianchi and Marco Valenti]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lelio Sabetti, Francesco Masedu, Chiara Tresca, Federica Bianchi and Marco Valenti</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171122]]></guid><cfi:id>105</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[In situ cornea harvesting through the Red Cross Organization: a new approach to relieving severe cornea donor shortage in Chinese eye banks]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Corneal diseases are currently the second main cause of blindness in China. Although most of the corneal blindness could be treated by corneal transplantation, only about 10 000 operations were carried out each year owing to the severe shortage of corneal donors and limited eye bank programs. A feasible cornea donation program was established through the organization of the Red Cross, and in situ corneal removal techniques were developed to avoid conflicts with Chinese traditions of keeping the deceased intact. The number of donated corneas, which had a safe and secure quality, increased significantly year by year.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Su-Xia Li, Fu-Hua Wang, Ting Wang, Sha-Sha Han and Wei-Yun Shi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Su-Xia Li, Fu-Hua Wang, Ting Wang, Sha-Sha Han and Wei-Yun Shi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171020]]></guid><cfi:id>104</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of the iridocorneal angle with accommodation using optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The changes in the iridocorneal angle structure during accommodation are assessed by means of anterior segment optical coherence tomography. Thirteen right eyes were included in the study. The device used for the measurement was the Visante&#174; omni system. The stimuli were set up at different vergences (0.0 D, -1.5 D, and -3.0 D). The angle opening distance 500 and 750, the trabecular iris space area 500 and 750, and the scleral spur angle parameters were assessed at the nasal and temporal regions. The results in the iridotrabecular angle comparing the three accommodative states of the eye did not yield any statistically significant difference at nasal or temporal angle sections. In light of our results and in the conditions of our study, the structures of the iridocorneal angle are not significantly changed with accommodation.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Daniel Monsálvez-Romín, Antonio Del águila-Carrasco, Teresa Ferrer-Blasco, José J. Esteve-Taboada and Robert Montés-Micó]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Daniel Monsálvez-Romín, Antonio Del águila-Carrasco, Teresa Ferrer-Blasco, José J. Esteve-Taboada and Robert Montés-Micó</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171021]]></guid><cfi:id>103</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A novel NF1 frame-shift mutation c.703_704delTA in a Chinese pedigree with neurofibromatosis type 1]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180922]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We analyzed the clinical features and NF1 gene mutation in a Chinese pedigree of neurofibromatosis type 1 (NF1). Three members of this family were NF1 patients presenting with different clinical phenotypes and the others were asymptomatic. Exons of NF1 were amplified by polymerase chain reaction, sequenced, compared with a reference database. One novel NF1 frame-shift mutation c.703_704delTA, which resulted in a premature stop signal at codon 720 and the synthesis of truncated, was revealed. This mutation segregated with the NF1 members is likely responsible for the pathogenesis of NF1 in the family.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jun Chen, Bo Guo, Min Ren, Hong Lin, Xin Zhang, Si-Yi Chen, Xiao-Tian Yu and Zhu-Ping Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun Chen, Bo Guo, Min Ren, Hong Lin, Xin Zhang, Si-Yi Chen, Xiao-Tian Yu and Zhu-Ping Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180922]]></guid><cfi:id>102</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual and morphological outcomes of vitreomacular traction syndrome in retinitis pigmentosa treated by vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180825]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Retrospective review of 13 eyes that had undergone pars plana vitrectomy (PPV) for vitreomacular traction  (VMT) syndrome in retinitis pigmentosa (RP) and had a postoperative follow-up period ≥9mo in order to evaluate whether it is necessary to treat VMT in RP by vitrectomy. The 13 RP eyes suffering from VMT were evaluated by means of best corrected visual acuity (BCVA), anterior and posterior binocular examination, spectral-domain optical coherence tomography (SD-OCT) before and after operation. We detected that although vitrectomy could improve the macular morphology in some RP patients with VMT, visual outcomes might be limited and unpredicted most likely because of the long-standing retinal dysfunction, but the vitrectomy is necessary in order to remain or improve the central vision in some cases.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Feng Yan, Feng-Jie Xia, Feng Jiang and Hyeong Gon Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Feng Yan, Feng-Jie Xia, Feng Jiang and Hyeong Gon Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180825]]></guid><cfi:id>101</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of anterior segment optical coherence tomography findings in acanthamoeba keratitis and herpetic epithelial keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180826]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study is to investigate the characteristic features of Acanthamoeba keratitis (AK) that differentiating it from herpetic epithelial keratitis (HEK) using anterior segment optical coherence tomography (AS-OCT). Medical records of three eyes of each AK and herpetic keratitis who had AS-OCT examination were reviewed in this study. Slit-lamp biomicroscopy and AS-OCT was performed on the initial visit and on every follow-up visits in all patients. In all three AK cases, reflective bands in the corneal stroma that correspond to the area of radial keratoneuritis were observed. The depth of the reflective bands varied in each case. After AK treatment, slit-lamp biomicroscopy confirmed that radial keratoneuritis had resolved and AS-OCT confirmed that reflective bands in the corneal stroma had also disappeared in all patients. Unlike the AS-OCT results found in AK, highly reflective HEK lesions were observed only in the subepithelial area, not in the stroma. AS-OCT seems to be helpful analyzing the specific depth of the lesion which enables to distinguish AK from HEK.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Young Min Park, Jong Soo Lee, Ji-Myong Yoo, Jong Moon Park, Seong-Wook Seo, In-Young Chung and Seong Jae Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Young Min Park, Jong Soo Lee, Ji-Myong Yoo, Jong Moon Park, Seong-Wook Seo, In-Young Chung and Seong Jae Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180826]]></guid><cfi:id>100</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in interleukin-6 tear concentration and clinical outcome in moderate-to-severe bacterial corneal ulcers after corneal collagen cross-linking]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180827]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We aimed to evaluate interleukin-6 (IL-6) tear concentration and clinical outcome in patients with moderate-to-severe bacterial corneal ulcers post corneal collagen cross-linking (CXL) therapy. This pre-post designed study involving 21 moderate-to-severe corneal ulcer patients who underwent CXL therapy. Patients with infectious corneal ulcer were given CXL therapy as adjunctive treatment after 5d of broadspectrum antibiotic treatment. Patients with moderate to severe infectious bacterial corneal ulcers were included in this study. Tear sampling was performed before CXL therapy, using sterile Schimer paper from conjunctival inferior fornix. CXL therapy was performed in accordance with the CXL Dresden protocol. Data recording and tear sampling were then performed at day 1 and day 7 after CXL therapy. Data recording included, presence of conjunctival hyperemia, visual analogue scale (VAS), size of corneal defects, and decemetocele. There was a decrease in IL-6 tear concentration by day 7 after CXL therapy (P=0.001). IL-6 concentration at 1h after therapy (2274.67±2120.46 pg/mL) tended to be lower than before therapy (4330.09±3169.70 pg/mL), but the difference was not statistically significant (P=0.821). The size of corneal defects decreased significantly post CXL (P=0.007). The logMAR visual acuity before and after CXL therapy was not found to be significantly different (P=0.277). There was a significant decrease in VAS values (P=0.018) and blepharospasm (P=0.011) pre and post CXL. There was no significant decrease in conjunctival hyperemia pre and post CXL (P=0.293). There was significant reduction in IL-6 tear concentration and clinical improvement in moderate-to-severe bacterial corneal ulcers which underwent CXL therapy.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Marzarendra Dhion Erlangga, Indra Tri Mahayana, Jajah Fachiroh, Angela Nurini Agni, Agus Supartoto and Suhardjo Pawiroranu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Marzarendra Dhion Erlangga, Indra Tri Mahayana, Jajah Fachiroh, Angela Nurini Agni, Agus Supartoto and Suhardjo Pawiroranu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180827]]></guid><cfi:id>99</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lateral rectus muscle recession and the vertical palpebral fissure height: to do or not to do inter-muscular septum dissection?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180625]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[In this study, we aimed to evaluate changes of vertical palpebral fissure height (VPFH) after unilateral lateral rectus muscle recession. Twenty-five and twenty-six patients who were candidates for lateral rectus muscle recession were assigned into “with” and “without” intermuscular septum dissection study arms. The VPFH was measured at one-day before surgery and in two weeks and three months, postoperatively. Three months after surgery, significant increase of VPFH was observed in both groups (Paired t-test; P=0.005). Also, less widening of VPFH was observed in “with intermuscular septum dissection” group (Change in VPFH in “with intermuscular septum dissection” vs “without intermuscular septum dissection” groups: 0.48 mm vs 1.34 mm; ANCOVA test; P<0.001). However, such results were not observed two weeks post-operatively (Change in VPFH in “with intermuscular septum dissection” vs “without intermuscular septum dissection” groups: -0.28 mm vs 0.28 mm; ANCOVA test; P=0.302). Intermuscular septum dissection is recommended in lateral rectus muscle recession to partially prevent the undesirable increment of VPFH.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Mohammad Ali Abtahi, Alireza Zandi, Eslam Mandegarfard, Hamidreza Jahanbani-Ardakani, Behzad Mahaki and Seyed-Hossein Abtahi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Ali Abtahi, Alireza Zandi, Eslam Mandegarfard, Hamidreza Jahanbani-Ardakani, Behzad Mahaki and Seyed-Hossein Abtahi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180625]]></guid><cfi:id>98</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reduction in interhemispheric functional connectivity in the dorsal visual pathway in unilateral acute open globe injury patients: a resting-state fMRI study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180626]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study investigated the changes in interhemispheric functional connectivity (FC) of the whole brain in open globe injury (OGI) patients, using voxel-mirrored homotopic connectivity (VMHC), and their relationships with clinical features. Totally, 16 male and 2 female acute OGI patients and 18 sex, age, and education-matched healthy volunteers were enrolled in the study. All subjects were scanned through functional magnetic resonance imaging (fMRI). Receiver operating characteristic (ROC) curves analyses had been used to identify the VMHC in these brain areas could be used as biomarkers to distinguish OGI and from healthy control (HC). The mean VMHC values in multiple brain areas and clinical OGI manifestations were evaluated with a Pearson correlation analysis. OGI patients had significantly decreased VMHC in the bilateral calcarine/lingual/cuneus (BA18, 19, 30) and middle occipital gyrus (BA18, 19). The OGI patients had abnormal interhemispheric FC in the dorsal visual pathway, which may represent the pathophysiological mechanism that underlies acute vision loss after OGI.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Lei Ye, Ran Wei, Xin Huang, Wen-Qing Shi, Qi-Chen Yang, Qing Yuan, Pei-Wen Zhu, Nan Jiang, Biao Li, Qiong Zhou, Fu-Qing Zhou and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lei Ye, Ran Wei, Xin Huang, Wen-Qing Shi, Qi-Chen Yang, Qing Yuan, Pei-Wen Zhu, Nan Jiang, Biao Li, Qiong Zhou, Fu-Qing Zhou and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180626]]></guid><cfi:id>97</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short and long-term outcomes of angle supported phakic intraocular lens implantation in high myopic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180527]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This cohort study included 36 eyes of 21 patients with high myopia treated with angle supported phakic intraocular lens (pIOL). Endothelial cell density (ECD) at baseline, 6mo and 3y were 3017±296, 2775±265 and 2558±299 cells/mm2 respectively. ECD loss at 6mo was 7.2% and annual ECD loss was 3% over 36mo. Corrected distance visual acuity at 36mo was 0.4 logMAR or better in 32 (88.9%) eyes. Intraocular pressure did not change (P=0.9). No eyes developed cataract, retinal detachment or pupillary distortion. Angle supported pIOL gives good visual outcome. Endothelial cell loss should be monitored.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Saeed Al-Qahtani, Khalid Al-Afraj, Mohanna Al-Jindan, Ali S Al-Beshri and Rajiv Khandekar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Saeed Al-Qahtani, Khalid Al-Afraj, Mohanna Al-Jindan, Ali S Al-Beshri and Rajiv Khandekar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180527]]></guid><cfi:id>96</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Cryopreserved limbal lamellar keratoplasty for peripheral corneal and limbal reconstruction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180427]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study aimed to evaluate the outcomes and described the recovery process of cryopreserved limbal lamellar keratoplasty (CLLK) for peripheral corneal and limbal diseases. Thirteen eyes of 12 patients with a mean age of 41±23.9y were included. The average follow-up was 12.1±5.6mo. Stable ocular surface was achieved in all eyes at last follow-up. Epithelialization originated from both recipient and graft in 9 eyes. We conclude that CLLK compensates for the shortage of donor corneas and cryopreserved limbal grafts provide epithelialization sources in ocular surface reconstruction.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Hua-Tao Xie, Jing Li, Yang Liu, Dong-Ling Jiang, Rui-Fen Shen and Ming-Chang Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hua-Tao Xie, Jing Li, Yang Liu, Dong-Ling Jiang, Rui-Fen Shen and Ming-Chang Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180427]]></guid><cfi:id>95</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lamellar keratoplasty with corneoscleral graft for limbal dermoids]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180324]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To assess the postoperative outcomes of limbal dermoid excision with corneoscleral graft transplantation. The charts of 8 consecutive patients (mean age: 13.0y) who had undergone limbal dermoid excision with lamellar corneoscleral graft transplantation by a single surgeon were retrospectively reviewed. Mean dermoid size was 7.75 mm (6.0-12.0 mm). Mean visual acuities (in logMAR units) before and after surgery were 1.8 and 1.7, respectively (P=0.29). Spherical equivalents were 1.3 diopter (D) before surgery and 0.7 D after surgery (P=0.40). The mean astigmatism measurements before and after surgery were 2.4 D and 1.5 D, respectively (P=0.17). Vector analysis revealed a mild change in astigmatism with a mean “d” of 3.2 (0.56-6.89). No intra- or post-operative complications occurred. Lamellar keratoplasty for limbal dermoids is safe and offers good cosmesis and tectonic stability. A significant decrease in the amount of astigmatism is not expected following surgery.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Oriel Spierer, Daniel Gologorsky, Eldad Adler and Richard K. Forster]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Oriel Spierer, Daniel Gologorsky, Eldad Adler and Richard K. Forster</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180324]]></guid><cfi:id>94</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A comparison of surgical efficacy between a 1.8-mm microincision and 3.2-mm and 5.5-mm incisions for phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180325]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Phacoemulsification is a commonly used surgical method in cataract surgery. This paper observes and compares the surgical efficacy of three incisions of different length for phacoemulsification to identify the optimal method for cataract surgery. Ninety patients were enrolled in the present study and divided into three groups. The 1.8-mm group received Bausch & Lomb MI60 foldable intraocular lens (IOL) implantation (n=30), 3.2-mm group received Bausch & Lomb Akreos AO foldable lens implantation (n=30), and 5.5-mm group received Alcon TYPE 05 rigid IOL implantation (n=30). Visual acuity, Oculyzer-based anterior segment analysis, and corneal endothelial cell count before surgery, and 3, 7, 30, and 90d after surgery were recorded and compared. Pseudophakic accommodation three days, one week, one month, and three months after surgery was determined. Intraoperative ultrasound time and ultrasonic energy were recorded. It was finally concluded that for phacoemulsification with the same phaco tip, a 1.8-mm microincision can lead to quicker recovery of visual acuity, more stable astigmatism, and higher pseudophakic accommodation than conventional incision.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[E Song, Xin Li, Ming-Chao Bi, Hua Ren, Dan Wang, Zhi-Hua Cui, Wei Yang, Hui Shi and Ya-Bin Sun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>E Song, Xin Li, Ming-Chao Bi, Hua Ren, Dan Wang, Zhi-Hua Cui, Wei Yang, Hui Shi and Ya-Bin Sun</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180325]]></guid><cfi:id>93</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Toxocara optic neuropathy: clinical features and ocular findings]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180326]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We evaluated thirteen eyes of twelve patients diagnosed clinically and serologically with Toxocara optic neuropathy. Eleven patients had unilateral involvement and one patient had bilateral optic neuropathy. Eight patients (66.7%) had a possible infection source to Toxocara. Six patients (50%) had painless acute optic neuropathy. Ten eyes had asymmetric, sectorial optic disc edema with peripapillary infiltration and three eyes had diffuse optic disc edema. Eosinophilia was noted in five patients (41.7%) and optic nerve enhancement was observed in eight of eleven eyes (72.7%) with available orbit magnetic resonance imaging (MRI). Mean visual acuity significantly improved following treatment [mean logarithmic of the minimum angle of resolution (logMAR) 0.94±0.56 at baseline and 0.47±0.59 at the final (P=0.02)]. Asymmetric optic disc edema with a peripapillary lesion and a history of raw meat ingestion were important clues for diagnosing Toxocara optic neuropathy. Additionally, Toxocara IgG enzyme-linked immunosorbent assay (ELISA) test and evaluating eosinophil may be helpful for diagnosis.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Kwang-Dong Choi, Jae-Hwan Choi, Seo-Young Choi and Jae Ho Jung]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kwang-Dong Choi, Jae-Hwan Choi, Seo-Young Choi and Jae Ho Jung</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180326]]></guid><cfi:id>92</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of Qingguang’an II on expressions of OX42 protein and IL-1β mRNA of retinal microglia cells of rats with chronic high intraocular pressure]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180223]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The study investigated the effects of Qingguang’an II (a Chinese medicinal preparation) on expressions of OX42 protein and interleukin-1β (IL-1β) mRNA of retinal microglia cells of rats with chronic high intraocular pressure (IOP). SD rats were randomly divided into 6 groups, that were: A: blank group; B: model group; C: Qingguang’an II low dose group; D: Qingguang’an II medium dose group; E: Qingguang’an II high dose group; F: Yimaikang disket (a Chinese medicinal preparation) group. Experimental rats in B, C, D, E, F groups were established the model of chronic high IOP by cauterizing of superficial scleral vein. Tissues of eyes were obtained after intragastric administration for 2 and 4wk. At the time-point of 2wk, OX42 protein and IL-1β mRNA in group B were statistically expressed in higher level comparing with other groups (P<0.05). Moreover, at the time-point of 4wk, OX42 protein and IL-1β mRNA in groups C, D and E were statistically expressed in lower level comparing with group F (P<0.05). Besides, OX42 protein and IL-1β mRNA in groups C and D were statistically expressed in higher level comparing with group E (P<0.05). OX42 protein and IL-1β mRNA in groups C and D were expressed in similar level (P>0.05). The study indicated that, in the protection of optic nerve of rats with chronic high IOP, the high dose of Qingguang’an II at the time-point of 4wk was the better choice.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ya-Sha Zhou, Jian Xu, Jun Peng, Yue Liu, Gen-Yan Qin, Yi-Jing Yang, Qing-Hua Peng and Han-Yu Tan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Sha Zhou, Jian Xu, Jun Peng, Yue Liu, Gen-Yan Qin, Yi-Jing Yang, Qing-Hua Peng and Han-Yu Tan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180223]]></guid><cfi:id>91</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Mechanism of delayed conduction of fellow eyes in patients with optic neuritis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180224]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To test the hypothesis that latency delay in the fellow eyes of optic neuritis (ON) patients and to compensate for delayed transmission of visual information, latency change of multi-focal visual evoked potential (mfVEP) traces in fellow eyes of 15 ON patients were analyzed. Patients with low risk (LR) for developing multiple sclerosis (MS) were examined separately from MS patients to isolate effect of cortical plasticity from potential pathological changes in disseminated disease. The small increase in latency in fellow eyes of LR group was statistically not significant. In MS patients, the latency was significantly delayed (P<0.02). The magnitude of the latency change in the fellow eyes did not correlate with the severity of latency delay in the affected eyes (R2<0.02, P=0.3). The differences between ON patients with and without MS, reported here, suggest that the presence of disseminated disease plays critical role in latency delay of the fellow eye.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Daniah Alshowaeir, Con Yiannikas, Clare Fraser and Alexander Klistorner]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Daniah Alshowaeir, Con Yiannikas, Clare Fraser and Alexander Klistorner</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180224]]></guid><cfi:id>90</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long term outcomes for patients treated with half-fluence photodynamic therapy for chronic central serous chorioretinopathy: a case series]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180225]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[A case series was used to evaluate the efficacy of half-fluence photodynamic therapy (PDT) for chronic central serous chorioretinopathy (CSCR). Patients were treated with standard-dose verteporfin and half-fluence PDT. Totally 13 eyes from 11 patients were included. The mean patient age was 52.0y. There was a mean reduction in central retinal thickness of 107.0 microns. Totally 7/13 eyes (53.8%) achieved resolution of subretinal fluid (SRF) on optical coherence tomography (OCT) scan after 1 treatment with PDT. Four eyes had further treatment with PDT; of these 1 eye achieved resolution of SRF. Seven of the 13 eyes (53.8%) achieved an improvement of more than 5 ETDRS letters. One patient experienced acute macula oedema 1d post PDT treatment. These results support the hypothesis that half-fluence PDT can have a positive effect in chronic CSCR for a gain in visual acuity and reduction in sub-retinal fluid. Acute macula oedema is a rare but potential adverse effect of half-fluence PDT.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jennifer Doyle, Bhaskar Gupta and Irfan Tahir]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jennifer Doyle, Bhaskar Gupta and Irfan Tahir</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180225]]></guid><cfi:id>89</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Amniotic membrane transplantation with topical interferon alfa-2b after excision of ocular surface squamous neoplasia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180124]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To evaluate the outcome of amniotic membrane transplantation (AMT) after tumor excision followed by topical interferon alfa-2b (IFNα2b) drops for primary ocular surface squamous neoplasia (OSSN). Twelve eyes of 12 patients with a mean age of 66±10y were included. The average follow-up was 23±10mo. All 12 patients had limbal involvement. Smooth ocular surface and transparent cornea were achieved in all cases. No sign of inflammation, neovascularization, symblepharon or recurrence was noted at the last follow-up. We conclude that AMT with topical IFNα2b drops restores a healthy ocular surface in OSSN without recurrence.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Hua-Tao Xie, Ying-Ying Zhang, Dong-Ling Jiang, Jun Wu, Jia-Song Wang and Ming-Chang Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hua-Tao Xie, Ying-Ying Zhang, Dong-Ling Jiang, Jun Wu, Jia-Song Wang and Ming-Chang Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180124]]></guid><cfi:id>88</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prevalence of glaucoma in the Israeli Arab population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180125]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We describe the prevalence and treatment of glaucoma in a Muslim Arab population in Israel. Based on the medical records of 15 122 persons, the overall prevalence of glaucoma was 3.9%. Prevalence rates of primary open angle glaucoma (POAG) and primary angle-closure glaucoma (PACG) were 3.0% and 0.42%, respectively. Prevalence rates of women were 135% that of men considering all types of glaucoma, 143% for POAG, and 96% for PACG. Prostaglandin analogs and beta blockers, alone or combined with carbonic anhydrase inhibitors, were the preferred medications. Of 68 patients who underwent trabeculectomy, 27 (39.7%) required medications, postoperatively, for treatment of glaucoma; following Ex-Press shunt surgery, 3/11 (27.3%) required medications. During the last three years, 16 (1.3%) individuals with POAG were recorded as legally blind as a result of glaucoma.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Otzem Chassid, Irena Epstein, Adi Sharabi-Nov and Joseph Pikkel]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Otzem Chassid, Irena Epstein, Adi Sharabi-Nov and Joseph Pikkel</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180125]]></guid><cfi:id>87</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of two different doses of intravitreal bevacizumab with temporal retina-sparing laser photocoagulation for retinopathy of prematurity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180126]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study aims to compare the efficacy and safety between two different doses of intravitreal bevacizumab (IVB) injection with temporal retina-sparing laser (TRSL) photocoagulation for retinopathy of prematurity (ROP). We retrospectively evaluated 22 eyes of ROP infants who underwent IVB combined with partial TRSL for stage 3+ zone I or posterior zone II ROP. Laser photocoagulation was applied on the avascular retina, sparing two-disc-diameter width temporal avascular area anterior to ridge. A half dose (0.625 mg) or minimal dose (0.25 mg) of IVB was conducted. Four eyes in minimal dose group were retreated with IVB and laser photocoagulation on the spared retina. Of those 4 retreated eyes, three developed preretinal hemorrhage around the ridge after the first treatment, resulting in fibrotic macular dragging. A half dose of IVB may be more effective than a minimal dose with partial TRSL for ROP. Preretinal hemorrhage may be a harbinger of poor prognosis.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[A Young Choi, Hochan Cho and Yu Cheol Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>A Young Choi, Hochan Cho and Yu Cheol Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180126]]></guid><cfi:id>86</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Episcleral brachytherapy as an effective alternative in vasoproliferative tumors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181223]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The aim of this study is to assess the results of episcleral brachytherapy as treatment of retinal vasoproliferative tumors (RVTs) in a referral Intraocular Tumors Unit (ITU). A retrospective review of all patients diagnosed with vasoproliferative tumors of the retina and treated with episcleral brachytherapy in the ITU, University Hospital of Valladolid between 2009 and 2015 was done. Five patients accomplished the inclusion criteria. All of them presented associated exudation and secondary retinal detachments (RD). Four patients had received prior treatments. Decreased tumor size and exudation regression was found in all cases after treatment. Visual acuity remained stable or increased in all patients. No recurrences have been found after twelve-months follow up. The results of the present study suggest that episcleral brachytherapy is an efficient and safe option in the management of vasoproliferative tumors, especially when large tumor or extensive subretinal fluid is present. In these cases episcleral brachytherapy could be considered as a first line treatment.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Marta Para Prieto, Maria Antonia Saornil, Jesús María de Frutos Baraja, Ciro Garc&iacute;a &Aacute;lvarez, Patricia Diezhandino García and Francisco López Lara]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Marta Para Prieto, Maria Antonia Saornil, Jesús María de Frutos Baraja, Ciro Garc&iacute;a &Aacute;lvarez, Patricia Diezhandino García and Francisco López Lara</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181223]]></guid><cfi:id>85</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical and laboratory features of PCR-confirmed periocular tuberculosis in China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181120]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Experts lack knowledge of periocular tuberculosis (TB) in China. Nested polymerase chain reaction (PCR) shows advantages in diagnosis of extrapulmonary TB. Our study aims to explore the clinical and laboratory features of PCR-confirmed periocular TB. We retrospectively reviewed medical records of presumptive periocular TB and performed nested PCR test to confirm diagnosis. Nine cases were recruited. Clinical symptoms were chronic and insidious. Eight cases achieved favorable visual acuity, while one underwent enucleation due to fungal-TB panophthalmitis. Sensitivity of caseous necrosis, acid-fast bacilli (AFB) staining and interferon γ release assay (T-SPOT) test are 33.3%, 44.4% and 85.7% respectively. Low lymphocyte percentage (P=0.019) and high monocyte-lymphocyte ratio (P=0.042) positively correlate with AFB staining. Male gender (P=0.048) and Langhans giant cell (P=0.048) positively correlate with caseous necrosis. To conclude, traditional TB ancillary tests are not as sensitive as nested PCR technique. Several factors facilitate diagnosis including male gender, decreased lymphocytes, and typical Langhans giant cells.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Rui-Qi Ma, Lu Gan, Ying-Wen Bi, Yi-Fei Yuan, Hui Ren and Jiang Qian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui-Qi Ma, Lu Gan, Ying-Wen Bi, Yi-Fei Yuan, Hui Ren and Jiang Qian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181120]]></guid><cfi:id>84</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Posterior chamber phakic intraocular lens for the correction of high myopic anisometropic amblyopia in adults]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181121]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study aims to evaluate the clinical results of posterior chamber implantable collamer lens (ICL) implantation in adults with high myopic anisometropic amblyopia. Thirteen patients aged 27.04±7.24y (range 19.2 to 42.5) were studied. ICL implantation was performed in 13 amblyopic eyes. The mean myopic anisometropia was significantly dropped from -10.70±3.02 D preoperatively to +0.09±1.67 D at 1mo postoperatively. The logMAR CDVA at 3d, 1, 3 and mean 9mo postoperatively improved by a mean of 1.69, 2.50, 3.01 and 3.00 lines and gained more than 2 lines accounted for 23.08% (3 eyes), 41.67% (5 eyes), 63.63% (7 eyes) and 55.56% (5 eyes), respectively. The contrast sensitivity of amblyopic eyes was significantly increased after surgery. Four patients partially recovered near stereopsis (400” to 100”). There was no severe complications were observed. ICL implantation alone can improve vision, contrast sensitivity, and partial restoration of binocular vision in adult patients with high myopic anisometropia.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jing Zhang, Jing Zhuang and Ke-Ming Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang, Jing Zhuang and Ke-Ming Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181121]]></guid><cfi:id>83</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[X-linked juvenile retinoschisis: phenotypic and genetic characterization]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181122]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Juvenile X-linked retinoschisis (XLRS, MIM#312700) belongs to a group of the vitreoretinal dystrophies. We aimed to describe the phenotype-genotype correlation of three XLRS cases in juveniles with different novel mutations from the Lithuanian population. The patients demonstrated macular retinoschisis and typical cyst-like cavities on spectral-domain optical coherence tomography (SD-OCT) images. The mean central foveal thickness was 569.7 μm. Two patients presented with peripheral retinoschisis. Flash electroretinogram demonstrated a reduced b/a ratio (<1.0) in all patients. RS1 (NM_000330.3) gene coding exons Sanger sequencing was performed. RS1 c.599G>T (p.R200L) mutation was detected in one case, showing to be pathogenic in silico analysis. c. (92_97) insC (p.W33fs) mutation was identified for another patient, indicating the variant is possibly damaging in silico analysis. The third case was identified with a pathogenic mutation c.422C>G (p.R141H), HGMD CM981753. These are the first cases of XLRS in the Lithuanian population confirmed by molecular genotyping. Presented patients had a different genotype but similar phenotypic traits.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Rasa Strupait&#279;, Laima Ambrozaityt&#279;, Loreta Cimbalistien&#279;, Rimvydas A&#353;oklis and Algirdas Utkus]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rasa Strupait&#279;, Laima Ambrozaityt&#279;, Loreta Cimbalistien&#279;, Rimvydas A&#353;oklis and Algirdas Utkus</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181122]]></guid><cfi:id>82</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Superficial foveal avascular zone area changes before and after idiopathic epiretinal membrane surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To investigate the foveal morphological changes and foveal avascular zone (FAZ) area before and after epiretinal membrane (ERM) surgery. Twenty-two eyes with treatment-naive ERM were included in this retrospective study. The central foveal thickness (CFT) and FAZ area were measured via swept-source optical coherence tomography (SS-OCT) and OCT angiography pre- and postoperatively. The unaffected fellow eyes were used as controls. The preoperative superficial FAZ area was significantly smaller in patients (0.08±0.04 mm2) than in controls (0.33±0.09 mm2; P<0.001). The postoperative superficial FAZ (0.12±0.06 mm2) area was significantly greater than the preoperative area (P<0.001). The preoperative superficial FAZ area was strongly negatively correlated with CFT (P<0.001, rho=-0.763). ERM induced significant foveal morphological changes and reduction of the superficial FAZ area. Foveal thickness was restored and FAZ area increased postoperatively. However, the process is rather slow and the recovery is incomplete.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Yo Sep Yoon, Je Moon Woo, Jong Eun Woo and Jung Kee Min]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yo Sep Yoon, Je Moon Woo, Jong Eun Woo and Jung Kee Min</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181021]]></guid><cfi:id>81</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The lived experiences of patients undergoing acellular porcine corneal stroma transplantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181022]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To explore the lived experiences of patients undergoing acellular porcine corneal stroma (APCS) transplantation, a descriptive, qualitative design was performed. A purposive sample of 13 patients who underwent APCS transplantation to treat progressive infectious keratitis were enrolled in the semi-structured, open-ended interviews. The taped and transcribed interviews were analyzed using a thematic analysis approach. Alterations in the transparency of APCS grafts were accompanied by a gradual improved visual acuity (before surgery: 1.38± 0.91 logMAR; 3mo postoperatively: 0.40±0.24 logMAR, respectively). Accordingly, in terms of lived experiences, the patients generally reported “negative” experiences before the operation and during the early postoperative period, but this was greatly improved 3mo after surgery. Four main themes were derived: anxiety and fear, stigma, lifestyle change, and gratitude and insights. Conclusively, health care professionals should provide holistic care for patients, proactively promoting patients’ physical and mental health.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Bi-Shan Tian, Sai-Qun Li, En-En Zhang, Hui-Ming Xiao, Li-Jin Su, Jun-E Zhang and Jin Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bi-Shan Tian, Sai-Qun Li, En-En Zhang, Hui-Ming Xiao, Li-Jin Su, Jun-E Zhang and Jin Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181022]]></guid><cfi:id>80</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Systemic IL-1β production as a consequence of corneal HSV-1 infection-contribution to the development of herpes simplex keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190919]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study sought to identify potential therapeutic targets in herpes simplex keratitis (HSK) patients with active and inactive infection by investigating peripheral cytokine production. Peripheral blood mononuclear cells (PBMCs) and serum were prepared from healthy controls and HSK patients during active infection or following treatment (inactive infection). Serum antibody titres were determined by ELISA. Protein expression levels were analysed by Western blot. Cytokine levels were determined by multiplex ELISA. Active corneal herpes simplex virus type 1 (HSV-1) infection resulted in significantly elevated peripheral levels of IL-1β in HSK patients compared to healthy controls, and remained significantly increased following treatment. Elevated production of IL-1β in inactive patients was associated with significantly increased levels of IRF3 and STAT1, key proteins involved in promoting anti-viral immune responses. Our data suggest that inflammation persists beyond the period that it is clinically evident and that enhanced peripheral production of IL-1β may have implications for HSV-1 viral clearance in active and inactive HSK patients.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Joan Ní Gabhann-Dromgoole, Ciaran de Chaumont, David Shahnazaryan, Siobhán Smith, Conor Malone, Jaythoon Hassan, Cillian F. De Gascun, Caroline A. Jefferies and Conor C. Murphy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Joan Ní Gabhann-Dromgoole, Ciaran de Chaumont, David Shahnazaryan, Siobhán Smith, Conor Malone, Jaythoon Hassan, Cillian F. De Gascun, Caroline A. Jefferies and Conor C. Murphy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190919]]></guid><cfi:id>79</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment of upper and lower lacrimal punctal occlusion using retrograde canaliculotomy and punctoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190920]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This is a retrospective, noncomparative analysis of a case series to explore the safety and effectiveness of retrograde canaliculotomy and punctoplasty for treating epiphora due to upper and lower lacrimal punctal occlusion. During the procedure, the horizontal portion of the normal lower canaliculus was identified; the corresponding punctum was reconstructed via retrograde canaliculotomy and punctoplasty. Intubation was performed to prevent postoperative reocclusion. Patients were followed up for 12 to 24mo. A total of 16 patients with unilateral upper and lower lacrimal punctal occlusion were included. Satisfactory outcomes were achieved: all 16 patients exhibited improvement of epiphora; 31 rebuilt punctal openings and canaliculi achieved recanalization. Only one upper punctal opening could not be reconstructed because the corresponding canaliculus exhibited severe injury. No significant complications occurred as a result of the treatments. Retrograde canaliculotomy and punctoplasty appears to effective, safe, and minimally invasive for treatment of upper and lower punctal occlusion.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ai Zhuang, Jing Sun and Wo-Dong Shi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ai Zhuang, Jing Sun and Wo-Dong Shi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190920]]></guid><cfi:id>78</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Xen45 Gel Stent implant: patient reported outcomes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190921]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Our aim was to report quality of life (QOL) outcomes following Xen45 Gel Stent implantation surgery in patients suffering with primary open angle glaucoma (POAG). A retrospective analysis was performed on all patients who had Xen45 implantation surgery during a 2-year period (Jun, 2016-Apr, 2018). Of 52 consecutive patients were included with a total of 58 eyes being operated on. QOL was compared both pre-operatively and 6 weeks post-operatively using the GQL-15 questionnaire. There was an overall improvement in GQL-15 summary scores for our patient group. All item scores showed either no change or some degree of improvement. The Xen45 Gel Stent Implant is a promising new intervention which has shown improved QOL scores in our patient group. Further, higher power studies are now needed to compare the Xen45 to trabeculectomy (TE), which is currently the gold standard.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Faaiq Hassan, Luke Thomas Middleton Thomson, Gurpal Toor and Qusay Alfahad]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Faaiq Hassan, Luke Thomas Middleton Thomson, Gurpal Toor and Qusay Alfahad</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190921]]></guid><cfi:id>77</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The heterozygous EDNRB mutation in a Chinese family with Waardenburg syndrome type I]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190922]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The genovariation of endothelin receptor type B (EDNRB) was identified in a Chinese family with Waardenburg syndrome type I (WS1) in the present study. WS1 was diagnosed in a 19-year-old young man, his older sister and aunt according to WS consortium criteria. After extracting genomic DNA from the peripheral blood samples, the coding exons and intronic regions of EDNRB were sequenced. A missense heterozygous mutation was found in the coding region of exon 2 in the EDNRB gene on chormosome 13q22.3 of the proband. The same mutation was detected in the proband’s afflicted paternal aunt and first older sister. Subsequent polyphen analysis and three-dimensional modeling confirmed that the c.469A>G heterozygous mutation in EDNRB was possibly pathogenic. This is the first report of EDNRB mutation as a potential disease-causing mutation in Chinese patients with WS1.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Huan-Huan Cheng, Shi-Qi Ling, Pei-Zhen Zhao, Wei-Li Li and Juan Deng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Huan-Huan Cheng, Shi-Qi Ling, Pei-Zhen Zhao, Wei-Li Li and Juan Deng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190922]]></guid><cfi:id>76</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Phacoemulsification in eyes with corneal opacities after deep anterior lamellar keratoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190817]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To evaluate the maneuverability and efficacy of phacoemulsification and intraocular lens (IOL) implantation in eyes with corneal opacities after deep anterior lamellar keratoplasty (DALK), twelve eyes of 12 patients with mild to moderate corneal opacities after DALK and coexisting cataracts were analyzed retrospectively. Phacoemulsification and IOL implantation assisted with anterior capsule staining, as well as non-invasive optical fiber illumination, were performed on all eyes. No intraoperative or postoperative complications were noted. Mean corrected distance visual acuity (logMAR) improved from 1.24±0.17 to 0.73±0.22. Post-phaco intraocular pressure was maintained between 13 to 20 mm Hg in all cases throughout the follow-up period. Mean endothelial cell density decreased from 2258.42±205.94 to 1906.25±174.23 cells/mm2. Phacoemulsification and IOL implantation are safe and valid in eyes with mild to moderate corneal opacities after DALK and coexisting cataracts when assisted with anterior capsule staining and non-invasive optical fiber illumination.]]></description>
<pubDate>2019/7/9 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Hui Lin, Juan Zhang, Guo-Zhen Niu, Xin-Yu Huang, Yu-Shan Zhang, Chun-Yu Liu, Chang-Yue Zheng and Yan-Long Bi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Lin, Juan Zhang, Guo-Zhen Niu, Xin-Yu Huang, Yu-Shan Zhang, Chun-Yu Liu, Chang-Yue Zheng and Yan-Long Bi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190817]]></guid><cfi:id>75</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Adjustment of IOL power for the second eye based on refractive error of the first-operated eye]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190818]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study was to estimate refractive status of the second eye of those undergo bilateral cataract surgery based on the first-operated eye, and to evaluate the refractive error (RE) in the second eye after correcting 50% of the first-operated eye’s error when it exceeded ±0.50 diopter (D). In this prospective study, 80 patients were scheduled for cataract surgery in the second eye, who underwent cataract surgery in first eye 1-3mo previously. The RE of each eye postoperatively was determined according to SRK/T formula. When the first-eye refractive error (FERE) exceeded ±0.5 D, the intraocular lens (IOL) power of the second eye was adjusted 50% of the FERE. The second-eye refractive error (SERE) was measured 1mo after surgery. The FERE exceeded -0.50 D in 12 eyes (-0.675±0.16 D), and the adjusted SERE was -0.322±0.73 D (P<0.05). The FERE exceeded +0.50 D in 8 eyes (1.533±1.14 D), and the adjusted SERE was 0.168±1.36 D (P<0.05). The unadjusted SERE in 60 cases remained -0.38 to 0.42 D when the FERE within ±0.05 D. This prospective study confirmed that the prediction of the second eye could be improved by correcting 50% of FERE when this error exceeded ±0.50 D.]]></description>
<pubDate>2019/7/9 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jie Zhang, Xiao-Na Ning and Hong Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Zhang, Xiao-Na Ning and Hong Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190818]]></guid><cfi:id>74</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of individualized therapy for AIDS patients with cytomegalovirus retinitis in intravitreal ganciclovir injections]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190819]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The effect of intravitreal ganciclovir injection combined with intravenous infusion on acquired immune deficiency syndrome (AIDS) patients with cytomegalovirus retinitis (CMVR) was investigated. A total of 32 eyes in 23 AIDS patients diagnosed as CMVR from 2017 to 2018 were included in the retrospective study. All patients underwent induction therapy by using intravenous drip of the anti-cytomegalovirus (CMV) agent ganciclovir (5 mg/kg q12h) combined with intravitreal ganciclovir injection (3 mg/time, 2 times/wk). The visual acuity, fundus photographs, lesion location, and number of intravitreal injections were observed preoperatively and postoperatively. Totally 14 eyes were cured during induction therapy. The number of injections [4.13 (2 to 6)] in CMVR patients with peripherally fundus lesions were significantly lower than those with central lesions [4.89 (2 to 6)]. The individualized therapy of intravitreal ganciclovir injections for AIDS patients with CMVR can effectively reduce the numbers of intravitreal injections.]]></description>
<pubDate>2019/7/9 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Lian-Yong Xie, Chao Chen, Wen-Jun Kong, Kui-Fang Du, Chun-Gang Guo, Hong-Wei Dong and Wen-Bin Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lian-Yong Xie, Chao Chen, Wen-Jun Kong, Kui-Fang Du, Chun-Gang Guo, Hong-Wei Dong and Wen-Bin Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190819]]></guid><cfi:id>73</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intraocular lens implantation performed first to protect the posterior capsule in Morgagnian cataracts during phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190725]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study evaluated the safety of a modified method to implant an intraocular lens (IOL) into the capsular bag immediately after capsulorhexis with a whole or partial nucleus to protect the posterior capsule (PC) during phacoemulsification in a series of 12 Morgagnian cataracts. For 3 cases of hypermature cataracts with smaller and rigid nuclei, after a complete capsulorhexis, an IOL was directly inserted into the capsular bag, which protected the PC during the subsequent phacoemulsification process in the iris plate. For the other 9 cases with larger and softer nuclei, after the nucleus was partially emulsified, the IOL was inserted into the bag. Even with an obvious surge for some cases, the surgeries were uneventful in all 12 cases, with no PC rent or vitreous loss. IOL implantation into the capsular bag with a whole or partial nucleus can provide effective protection for the PC for hypermature cataract during phacoemulsification.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Xia Hua, Yongxiao Dong, Ling Wang, Zhiqing Li, Jianying Du, Wei Chi and Xiaoyong Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xia Hua, Yongxiao Dong, Ling Wang, Zhiqing Li, Jianying Du, Wei Chi and Xiaoyong Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190725]]></guid><cfi:id>72</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual and refractive outcomes of posterior chamber phakic IOL in stable keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190522]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We evaluated the visual and refractive outcomes after phakic visian toric implantable collamer lens (ICL) insertion in stable keratoconus (KC). This retrospective study investigated toric ICL implantation in 14 eyes of 8 patients with stable KC. After 6mo, the mean uncorrected distance visual acuity improved significantly from 0.77 to 0.15 logMAR. The mean best corrected distance visual acuity (BCDVA) improved from 0.18±0.1 to 0.15±0.1 logMAR. Fifty percent of eyes maintained their preoperative BCDVA; 42.8% gained one line. There was no statistical difference in high order or coma aberration. The mean refractive manifest spherical equivalent (MSE), mean refractive manifest spherical error, mean manifest astigmatism decreased significantly postoperatively. At 6mo postoperatively, our achieved mean spherical equivalent was approximately 74%. No intraoperative or postoperative complications occurred. Toric ICL implantation was effective, predictable and safe to correct refractive error and improve visual acuity in patients with stable KC.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Sherif H Emerah, Moataz M Sabry, Hisham A Saad and Waleed A Ghobashy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sherif H Emerah, Moataz M Sabry, Hisham A Saad and Waleed A Ghobashy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190522]]></guid><cfi:id>71</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of OA-2000 and IOL Master 500 using in cataract patients with high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190523]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study was designed to compare optical biometry measurements and predicted refraction in cataract patients with high myopia [axial length (AL) ≥26 mm] using OA-2000 and IOL Master 500. Ocular biometry measurements were performed using both biometers before surgery. Uneventful cataract surgery was performed in all patients. Postoperative manifest refraction was obtained 3wk after surgery or later. A total of 67 eyes were examined. The AL, keratometry (K), and anterior chamber depth (ACD) of the two biometers showed excellent agreement. Predicted errors were similar and a strong positive correlation was observed (r=0.909). Out of 21 eyes (31.34%) with unsuccessful AL readings using the IOL Master 500, 20 eyes of them could be measured using OA-2000. Therefore, the biometric parameters measured by the two biometers showed good agreement. However, OA-2000 had a lower AL measurement failure rate.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ya-Li Du, Geng Wang, Hui-Chun Huang, Li-Yu Lin, Chuang Jin, Li-Fang Liu, Xiu-Ru Liu and Ming-Zhi Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Li Du, Geng Wang, Hui-Chun Huang, Li-Yu Lin, Chuang Jin, Li-Fang Liu, Xiu-Ru Liu and Ming-Zhi Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190523]]></guid><cfi:id>70</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Free autologous internal limiting membrane transplantation in the treatment of large macular hole]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190524]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We evaluated the clinical efficacy of free internal limiting membrane (ILM) flap transplantation for the treatment of large macular hole over 500 μm in 42 consecutive patients. Quantified evaluation of the post-operative macular anatomy restoration was performed by spectral-domain optical coherence tomography in the 12mo follow-up. The results showed 41 eyes achieved successful closure (97.6%). Postoperative best corrected visual acuity, ellipsoid layer, and external limiting membrane disruption were significantly improved at all follow-up time points. The central foveal thickness was significantly higher at 1mo. We concluded that free ILM flap transplantation proves to be effective to achieve anatomical and functional improvement for the treatment of large macular hole.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Fei-Yan Ma, Rui-Jie Xi, Peng-Fei Chen and Yu-Hua Hao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fei-Yan Ma, Rui-Jie Xi, Peng-Fei Chen and Yu-Hua Hao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190524]]></guid><cfi:id>69</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The macular microstructure repair and predictive factors of surgical outcomes after vitrectomy for idiopathic macular hole]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190525]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To evaluate the macular microstructure repair and explore the factors related to those changes and visual improvement after vitrectomy for idiopathic macular hole (IMH). Totally 19 eyes of 18 IMH patients who underwent macular hole (MH) surgery were evaluated with best-corrected visual acuity (BCVA) and spectral-domain optical coherence tomography (SD-OCT) images. All 19 eyes closed at 6mo postoperatively. BCVA was observed gradually improved (P<0.001), with subretinal fluid (SRF) gradually absorbed (P=0.021) and the rate of external limiting membrane (ELM) defects gradually decreased (P=0.011) with follow-up time. Poorer postoperative logMAR BCVA correlated with larger MH minimum diameter (P<0.001), larger MH basal diameter (P=0.008), longer symptom duration (P=0.002) and poorer preoperative logMAR BCVA (P=0.010). More improvement in BCVA correlated only with poorer preoperative in logMAR BCVA (P=0.002). The earlier reconstruction of ELM was associated with smaller MH basal diameter (P=0.022) and shorter symptom duration (P=0.008). In conclusion, smaller basal diameter of MH and shorter symptom duration were key factors in earlier reconstruction of ELM.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jing-Ling Zou and Jun Zeng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Ling Zou and Jun Zeng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190525]]></guid><cfi:id>68</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation analysis and multiple regression formulas of refractive errors and ocular components]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190526]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The multiple regression formulas and correlation of ocular components with refractive errors are presented by Gaussian optics. The refractive error changing rate for the cornea and lens power, the axial length, anterior chamber depth (ACD) and vitreous chamber depth (VCD) are calculated, including nonlinear terms for more accurate rate functions than the linear theory. Our theory, consistent with the empirical data, shows that the Pearson correlation coefficients for spherical equivalent (SE) and ocular components are highest for SE with axial length, ACD and VCD and weakest for corneal power, lens power and lens thickness. Moreover, our regression formulas show the asymmetric feature of the correlation that the axial length, ACD and VCD are more strongly correlated (with higher negative regression constants) with refractive errors in eyes with hyperopia than in eyes with myopia, particularly for severe hyperopia.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Chao-Kai Chang, Jui-Teng Lin and Yong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chao-Kai Chang, Jui-Teng Lin and Yong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190526]]></guid><cfi:id>67</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Post-miosis changes in the anterior chamber structures in primary and lens-induced secondary chronic angle-closure glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190424]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To evaluate post-miosis changes in the anterior chamber structures in various angle-closure glaucomas (ACG). Totally 14 eyes of primary chronic angle-closure glaucoma (PCACG), 12 eyes of lens-induced secondary chronic angle-closure glaucoma (LSACG) and 14 healthy eyes were recruited. After miosis, for PCACG group, intraocular pressure (IOP) and anterior chamber depth (ACD) changed not significantly, while anterior chamber angle widened significantly. LSACG group showed a significant increase in IOP, decrease in ACD, and narrowing in anterior chamber angle. Healthy eyes showed significant decreases in IOP and anterior chamber parameters. Thus, miosis could widen the anterior chamber angle of patients with PCACG, while increase the narrowing of anterior chamber angle and IOP of patients with LSACG. We should pay attention to the distinction between PCACG and LSACG patients and the proper administration of pilocarpine in the treatment of patients with chronic ACG.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Mu Li, Xiao-Qin Yan, Gai-Yun Li and Hong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mu Li, Xiao-Qin Yan, Gai-Yun Li and Hong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190424]]></guid><cfi:id>66</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Role of microfluctuations in accommodation: a novel approach to reduce non-accommodative noise]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190425]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Accommodative response and its possible role in myopia development has been explored through the study of the microfluctuations (MFs) of accommodation, which are commonly divided in high (1.0 to 2.3 Hz) and low (0.1 to 0.6 Hz) frequency components. Previous research efforts have evidenced that a certain percentage of the amplitude of MFs seems not to originate in the accommodative response. We aimed to develop and test a new approach to reduce this non-accommodative noise. For this purpose, ten healthy participants were enrolled to determine the difference between the amplitude of MFs at near and distance for each range of frequencies, which was defined as the relative amplitude of MFs. The findings support the exploration of the relative rather than absolute values of the amplitude of MFs to better understand the contribution of both accommodative and non-accommodative factors to MFs.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Núria Lupón, Joan Gispets, Genis Cardona, Alba Tàpia and Hector Abril]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Núria Lupón, Joan Gispets, Genis Cardona, Alba Tàpia and Hector Abril</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190425]]></guid><cfi:id>65</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of the causative factors related to earlier emulsification of silicone oil]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190325]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The aim of this study is to report and analyze the factors related with earlier occurrence of silicone oil (SO) emulsification in patients underwent pars plana vitrectomy and SO injection in our hospital. We retrospectively reviewed consecutive case series undergone both SO injection and removal in our hospital, and 182 ones were eligible. Possible related independent factors included: macula status (on/off), concomitant phacoemulsification with the surgery of SO tamponading, concomitant status of proliferative vitreoretinopathy, combined surgery of retinotomy, time to have emulsification (<6mo/≥6mo after primary SO injection), route of SO injection (anterior/posterior), lens status (aphakic/pseudophakic/phakic), anesthesia (local/general), brands and type of SO, with/without episcleral cryotherapy, with/without hypertension, with/without diabetes, with/without intraoperative use of triamcinolone acetonide. The study revealed that brand and type of SO was the significant factor related with earlier emulsification of SO. Further study was warranted to find out the underlying causes.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Yao Ni, Hao Fang, Xia Zhang, Xiao-Feng Lin and Wen-Jun Guo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao Ni, Hao Fang, Xia Zhang, Xiao-Feng Lin and Wen-Jun Guo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190325]]></guid><cfi:id>64</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long term efficacy and stability of corneal collagen cross linking for post-LASIK ectasia: an average of 80mo follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190222]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study was designed to evaluate efficacy and stability of corneal collagen crosslinking (CXL) in halting the progression of post-laser in situ keratomileusis (LASIK) ectasia and provide long-term follow-up results with an average of 80mo. Patients with post-LASIK ectasia were treated with CXL between December 2007 and January 2012. Main outcome measures were uncorrected distance visual acuities (UDVA) and corrected distance visual acuities (CDVA), minimum and maximum keratometry (K) values, spherical and cylindrical refraction, and corneal thickness. The study evaluated 17 eyes for 13 patients (8 men, 5 women) with mean age of 31y (range 23 to 39) and mean follow-up of 80.7±15 (range 57 to 102)mo. UDVA and CDVA improved from logMAR 0.53±0.36 (20/63) to 0.49±0.4 (20/50) (P=0.43) and from 0.18±0.17 (20/28) to 0.16±0.16 (20/27) (P=0.55) respectively. In 15 eyes UDVA and in 13 eyes CDVA either remained stable or improved ≥1 Snellen lines (88.2%) and (76.5%) respectively. Although statistically insignificant, spherical and cylindrical refraction decreased post-CXL from -1.26±2.87 to -0.38±2.32 diopters (D) (P=0.054) and from -3.80±2.47 to -3.04±2.18 D (P=0.13) respectively. Kmax significantly decreased from 44.23±3.76 to 42.85±3.08 D (P=0.013) and Kmin decreased from 41.07±3.61 to 40.00±2.65 D (P=0.057). Corneal thickness decreased from 470±42 to 460±41 μm, but was statistically non-significant (P=0.063). Therefore, CXL is effective in halting and partially reversing the progression of post-LASIK ectasia on the long-term (mean follow-up of more than 80mo), thus highlighting the stability and maintained effect of CXL for such cases.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Walid Sharif, Zaid Rushdi Ali and Khaled Sharif]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Walid Sharif, Zaid Rushdi Ali and Khaled Sharif</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190222]]></guid><cfi:id>63</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intraocular inflammation after Ultrasound Cyclo Plasty for the treatment of glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190223]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This is a prospective interventional clinical study evaluating intraocular inflammation developed after Ultrasound Cyclo Plasty (UCP) for the treatment of glaucoma. Eighteen eyes of 18 patients were treated with UCP second-generation probes (Eye OP1). After treatment, the mean intraocular pressure (IOP) significantly decreased from 26.8±7.2 to 18.8±6.1 mm Hg at day 1 and to 14.7±3.4 mm Hg at month 6 (all P<0.001). Mean laser flare-cell photometry value steeply increased after surgery from 12.1±7.5 to 64.1±53.9 ph/ms (P=0.001) at day 1, and then progressively decreased to respectively 60.6±49.7 at day 7, 43.5±38.5 at day 14 and 28.2±18.3 at month 1 (all P<0.05), returning at levels similar to baseline ones at month 3 and month 6 (respectively 16.7±6.2 and 12.8±10.2, both P>0.05). A significant negative correlation was found between postoperative increase of aqueous flare values and anterior chamber depth (R=-0.568, P=0.014). This timeframe may be considered reasonable for repeating UCP treatment, when required.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Marco Pellegrini, Stefano Sebastiani, Giuseppe Giannaccare and Emilio C. Campos]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Marco Pellegrini, Stefano Sebastiani, Giuseppe Giannaccare and Emilio C. Campos</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190223]]></guid><cfi:id>62</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Navigated laser in diabetic macular edema: the impact of reduced injection burden on patients and physicians-who wins and who loses?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190224]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We inquired the impact of reduced therapy discontinuation in diabetic macular edema (DME) on physician’s revenue considering anti-vascular endothelial growth factor (VEGF) monotherapy and its combination with Navilas treatment. Data were collected on injection frequency, treatment discontinuation and reimbursement fees for DME treatment with anti-VEGF compared to anti-VEGF in combination with navigated laser. Based on these data an economic model was built to compare physicians revenue over a 5y period using either therapy for 4 European countries and the USA. Due to patients’ higher therapy adherence, physicians using navigated laser therapy with anti-VEGF generate similar or higher revenues compared to VEGF monotherapy in all analyzed countries. The use of Navilas decreases the patient’s injection burden at the same clinical outcome, while the physician’s revenue remained stable or increased. Therewith, therapy discontinuation in DME can be reduced using the combination therapy with Navilas.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jacob Menzler, Aljoscha Neubauer and Focke Ziemssen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jacob Menzler, Aljoscha Neubauer and Focke Ziemssen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190224]]></guid><cfi:id>61</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trans-scleral cyclophotocoagulation: a tale of two probes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190123]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To compare the histological effects of trans-scleral cyclophotocoagulation (TCP) performed with two different probes, the G-probe (IRIDEX Medical Instruments, Mountain View, CA, USA) and the Ciliprobe (Katalyst Surgical, Chesterfield, MO, USA). TCP was performed on two human cadaver eyes from the same corpse. The vertical meridian was marked and opposite sides were treated using either the G-probe or Ciliprobe. The first eye was treated with each probe at 2000ms/2000 mW and the second eye at 3000ms/1500 mW. Histological examination revealed separation and loss of the non-pigmented ciliary epithelium as well as vacuolization in all sections for both probes and settings. Changes to the non-pigmented ciliary epithelium treated at 3000ms/1500 mW were similar between the two probes. A slightly more complete separation of the non-pigmented epithelium was noted on the Ciliprobe treated sections as compared to the G-probe treated sections in the eye treated at 2000ms/2000 mW. Therefore, in human cadaver eyes, both the G-probe and Ciliprobe produced separation, vacuolization, and loss of the non-pigmented ciliary epithelium at two different, clinically utilized settings.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Cara E. Capitena Young, Malik Y. Kahook, David A. Ammar and Leonard K. Seibold]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cara E. Capitena Young, Malik Y. Kahook, David A. Ammar and Leonard K. Seibold</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190123]]></guid><cfi:id>60</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of encirclage and cryotherapy with argon laser in the management of traumatic cyclodialysis cleft]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190124]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The study compared anatomical and functional outcome of a novel technique of encirclage and cryotherapy with the conventional argon laser in the management of traumatic cyclodialysis cleft in 19 patients (10: encirclage and 9: argon laser). The postoperative anatomical success was taken as rise in intraocular pressure (IOP) more than 6 mm Hg or the closure of cleft on gonioscopy or ultrasound biomicroscopy (UBM). Visual outcome was measured as change in logMAR visual acuity. Traumatic cataract and hypotony were present in majority. IOP>6 mm Hg was noted in 90% of encirclage group and in 77.70% of argon laser group. Two cases had non-closure of cleft. Encirclage is comparable to argon laser in terms of anatomical and functional success with possible advantage of single procedure and use in cases with failed laser.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Gitanjli Sood, Vinata Rajendran, Ronnie George, Tarun Sharma and Rajiv Raman]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gitanjli Sood, Vinata Rajendran, Ronnie George, Tarun Sharma and Rajiv Raman</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190124]]></guid><cfi:id>59</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of glaucoma on identification of bottle cap color in ophthalmic medications]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190125]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[A prospective, nonrandomized, observational trial of 60 glaucoma patients to correlate visual acuity and visual field with ability to distinguish bottle cap color of commonly used ophthalmic medications was conducted. A total of 103 eyes from 60 patients (30 women) were evaluated. The mean logMAR acuity was 0.34±0.54 (approximately 20/45 Snellen acuity), average Humphrey Visual Field (HVF) mean deviation was -8.58±8.69 dB, mean Ishihara plates (out of 14) were 11.78±4.15, and bottle cap color score (out of 10) was 8.56±2.51. Multiple linear regression analysis revealed an independent correlation of visual acuity (P=0.0137) and Ishihara score (P<0.001) with cap color score, but no significant effect with visual field mean deviation (P>0.05). Glaucoma patients with poor visual acuity, but not necessarily advanced visual field loss, are likely to have difficultly identifying the color of their bottle caps. Physicians should be cognizant of this potential issue when reviewing medications with patients.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jonathan Paul, Jon David Hammer, Roozbeh Akhtari, Brede Skillings and Daniel B. Moore]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jonathan Paul, Jon David Hammer, Roozbeh Akhtari, Brede Skillings and Daniel B. Moore</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190125]]></guid><cfi:id>58</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of Acanthamoeba keratitis: a histological study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191220]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We analysed histologically two Acanthamoeba keratitis (AK) eyes with anterior and posterior segment inflammation and blindness. Two enucleated eyes of 2 patients (age 45 and 51y) with AK (PCR of epithelial abrasion positive) were analysed. Histological analysis was performed using hematoxylin-eosin, periodic acid-Schiff and G&#246;m&#246;ri-methenamine silver staining. We could not observe Acanthamoeba trophozoites or cysts neither in the cornea nor in other ocular tissues. Meanwhile, we found uveitis, retinal vasculitis and scleritis in these eyes, due to the long-standing, recalcitrant AK. So in this stage of AK, systemic immune suppression may be necessary for a longer time period.]]></description>
<pubDate>2019/11/6 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Lei Shi, Tobias Hager, Fabian Norbert Fries, Loay Daas, Leonard Holbach, Carmen Hofmann-Rummelt, Elena Zemova, Berthold Seitz and Nóra Szentmáry]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lei Shi, Tobias Hager, Fabian Norbert Fries, Loay Daas, Leonard Holbach, Carmen Hofmann-Rummelt, Elena Zemova, Berthold Seitz and Nóra Szentmáry</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191220]]></guid><cfi:id>57</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[IOL repositioning using iris sutures: a safe and effective technique]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191221]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This retrospective non-comparative consecutive case series study was conducted at Azienda Ospedaliera Universitaria Careggi, Florence, Italy and describes a useful intraocular lens (IOL) repositioning technique using iris sutures. In our study, 41 consecutive cases of posteriorly dislocated IOLs were surgically treated between January 2015 and May 2017. Six of the cases were post-traumatic luxations, and 20 patients had pseudoexfoliation syndrome. All the patients underwent pars plana vitrectomy and same IOL repositioning using iris sutures. The mean follow-up was 12.2mo. The mean preoperative best corrected visual acuity (BCVA) was 0.10±0.15 logMAR, whereas the mean postoperative BCVA was 0.08±0.14 logMAR. The mean postoperative BCVA did not change significantly from the preoperative BCVA. The final mean spherical equivalent was -0.44±0.49 SD. Three lenses (7.31%) were found tilted during post-operative follow-up. Two eyes (4.87%) had postoperative cystoid macular edema. No eyes had endophthalmitis, hypotony, retinal or choroidal detachment. The iris fixation technique seems to be a safe and valid option for the management of dislocated IOLs.]]></description>
<pubDate>2019/11/6 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Tomaso Caporossi, Ruggero Tartaro, Fabrizio GS Franco, Francesco Barca, Lucia Finocchio, Daniela Bacherini, Dario Giorgio, Fabrizio Giansanti and Stanislao Rizzo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tomaso Caporossi, Ruggero Tartaro, Fabrizio GS Franco, Francesco Barca, Lucia Finocchio, Daniela Bacherini, Dario Giorgio, Fabrizio Giansanti and Stanislao Rizzo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191221]]></guid><cfi:id>56</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The expression of MAPK signaling pathways in conjunctivochalasis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191121]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study investigated the potential role of MAPK signaling pathways in conjunctivochalasis (CCH). Twenty loose conjunctival biopsy samples from 20 CCH and 15 conjunctival biopsy samples from 15 normal controls (CON) were collected. The conjunctival fibroblasts were cultured in vitro. Immunofluorescence, ELISA, Western blot and reverse transcription-polymerase chain reaction (RT-PCR) were used. Our results showed that the expression of p-ERK, p-JNK, and p-p38 in CCH conjunctiva was significantly higher than that in CON group. The expression of p38 MAPK, JNK, and ERK proteins in CCH fibroblasts was significantly higher than that in CON group. The total expression of MAPK mRNA in CCH fibroblasts was significantly higher than that in CON group. The activated forms of p38 MAPK, JNK, and ERK proteins and mRNAs might up-regulate the expression of MMPs in CCH loose conjunctival tissue and fibroblasts, causing the degradation of collagen fibers and elastic fibers and promoting the occurrence of CCH. Our results deepen the understanding of CCH pathological mechanism.]]></description>
<pubDate>2019/10/8 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Yuan-Ling Jia, Xiao-Jing Liu, Hang Wen, Yue-Ping Zhan and Min-Hong Xiang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuan-Ling Jia, Xiao-Jing Liu, Hang Wen, Yue-Ping Zhan and Min-Hong Xiang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191121]]></guid><cfi:id>55</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation between obstructive sleep apnea and central retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To investigate the possible correlation between obstructive sleep apnea (OSA) and central retinal vein occlusion (CRVO). Thirty consecutive patients with a recent (<3mo) CRVO and an age- and sex-matched group of 30 control subjects were recruited. All subjects underwent full-night polysomnography to measure apnea-hypopnea index (AHI) and oxygen desaturation index (ODI). The average AHI and ODI were significantly higher in CRVO patients (AHI: 13.86±8.63, ODI: 9.21±4.47) than in control subjects (AHI: 8.51±6.36, ODI: 5.87±3.18; P=0.008 and 0.001 respectively). Additionally, the AHI was positively correlated with body mass index (BMI; r=0.476, P=0.017) and ODI (r=0.921, P<0.01) in both CRVO and control subjects. According to AHI scores, twenty-two (73.33%) CRVO patients had OSA and 12 (40.00%) control subjects had OSA, a difference that was statistically significant (P=0.019). OSA may be a risk factor for or a trigger of CRVO development.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Yan-Hui Wang, Peng Zhang, Lian Chen, Zhao Jiang, Lu-Xi Li, Ke He and Xiao-Qing Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Hui Wang, Peng Zhang, Lian Chen, Zhao Jiang, Lu-Xi Li, Ke He and Xiao-Qing Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191017]]></guid><cfi:id>54</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of 0.4% ripasudil hydrochloride hydrate on morphological changes in rabbit eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[We evaluated the cellular structure changes after continuous use of ripasudil hydrochloride hydrate in rabbit eyes which might affect its own efficacy and adverse effects. Two pigmented Dutch rabbits and 1 Japanese white rabbit were instilled with 0.4% ripasudil hydrochloride hydrate to the left eye twice daily. The right eye was observed as the control. Both eyes of all 3 rabbits were then enucleated for histopathologic examination by light and electron microscope at 1mo in 1 of the pigmented Dutch rabbits, 3mo in the other pigmented Dutch rabbit, and in the Japanese white rabbit after instillation. Microscopic observations showed increase intercellular space in trabecular meshwork, ciliary body, and iris stoma, increase pigmented granule number and size in iris epithelial cells, and decrease actin filament in iris muscle fiber cells. Consequently, ripasudil hydrochloride hydrate decreases the intraocular pressure by improving the conventional outflow and may also facilitate the unconventional outflow via intercellular space widening without serious side effects.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Bundit Limratchatamorn, Ken Asakawa, Kimiyo Mashimo, Shigekazu Uga and Hitoshi Ishikawa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bundit Limratchatamorn, Ken Asakawa, Kimiyo Mashimo, Shigekazu Uga and Hitoshi Ishikawa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191018]]></guid><cfi:id>53</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Functional outcome of the low vision aids for visual impairment secondary to central nervous system tumors in children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To assess functional outcomes of optical low vision aids (LVAs) for pediatric visual impairment due to central nervous system (CNS) tumors. A prospective case study was conducted on 15 children with history of CNS tumors with mean age of 10.47±1.85y. Lighthouse distance, near visual acuity tests, cycloplegic refraction, reading speed measurement and visual field examination were done. Prescription of far and near LVAs followed by training sessions. LVPrasad-functional vision questionnaire was done to evaluate performance. Visual impairment was moderate (13.3%), severe (73.3%), profound (6.7%) and near blindness in 6.7%. Telescopes prescribed in 33.4%, video magnifier in 46.7%. Questionnaire scores were significantly improved for distant rather than near tasks (P≤0.05) after training. LVAs rehabilitation is an effective method of improving vision in pediatric visual defects secondary to CNS tumors.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Rania GE Zaki, Reham F. Elshinawy and Karim M. Naguib]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rania GE Zaki, Reham F. Elshinawy and Karim M. Naguib</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191019]]></guid><cfi:id>52</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Scleral buckling combined with internal cyclopexy for severe traumatic cyclodialysis cleft in open globe injuries]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[This study aimed to evaluate the effect of scleral buckling combined with internal cyclopexy on the treatment of severe traumatic cyclodialysis cleft in open globe injuries (OGIS). This retrospective study recruited 10 patients of 10 eyes. With our surgical intervention, all the 10 eyes achieved retinal and ciliary body anatomic re-attachment. The choroidal ruptures in nine eyes were closed with complete choroidal reattachment. Postoperative best-corrected visual acuity of nine eyes had various improvements. The mean intraocular pressure was increased from 8.9±2.6 mm Hg to 13.4±4.4 mm Hg. Eventually, six eyes underwent silicone oil (SO) removal without complications, two eyes still had SO tamponade and two eyes became SO-dependent eyes. The result shows that internal direct cyclopexy combined with scleral buckling is an effective treatment for severe traumatic cyclodialysis cleft in OGIS.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Bo Chen, Gao-Xiang Wang, Xian Zhang and Hong Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo Chen, Gao-Xiang Wang, Xian Zhang and Hong Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191020]]></guid><cfi:id>51</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Management of cataract in keratoconus: early visual outcomes of different treatment modalities]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[A review of 31 eyes with keratoconus who developed cataract and underwent phacoemulsification. Visual acuities were measured 1mo postoperatively. Six eyes with a history of good corrected distance visual acuity (CDVA) and a similar refractive and topographic astigmatic axis were implanted with toric intraocular lenses (IOLs). The mean postoperative uncorrected distance visual acuity (UDVA) was 0.2 logMAR with a spherical equivalent (SE): 0.75D. Eleven eyes with a history of good CDVA and different refractive and topographic axis were implanted with monofocal IOL+/-Toric implantable collamer lenses to treat anisometropia and ametropia; mean UDVA was 0.25 logMAR with a mean SE: -0.51 D postoperatively. Six eyes with poor CDVA were first treated with intra-corneal ring segments, followed by phacoemulsification, the mean postoperative UDVA was 0.82 logMAR with an SE: 0.22 D. Eight eyes had advanced ectesia and received combined phacoemulsification and penetrating keratoplasty. Our approach is efficient in addressing ametropia after cataract surgery in keratoconic eyes.]]></description>
<pubDate>2019/10/9 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Nicolas Arej, Wassef Chanbour, Karen Zaarour, Mazen Amro, Hala El-Rami, Fadi Harb and Elias Jarade]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nicolas Arej, Wassef Chanbour, Karen Zaarour, Mazen Amro, Hala El-Rami, Fadi Harb and Elias Jarade</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191021]]></guid><cfi:id>50</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Incidence and predisposing factors of anterior chamber gas bubbles during femtosecond laser flap creation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200822]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the incidence and the predisposing factors of anterior chamber (AC) gas bubbles during femtosecond laser (FS) flap creation for laser in situ keratomileusis (LASIK).
METHODS: All patients who underwent FS-LASIK surgery at CMU LASIK Center between January 2013 and May 2016 were retrospective reviewed. Preoperative and intraoperative data including keratometry, white-to-white (WTW) corneal diameter, flap parameters (diameter, thickness, hinge position, and tunnel length) and pulse energy were reviewed and compared between incident group and control group. To determine the risk factors, univariate and multivariate conditional logistic regression were used; the eye was unit of analysis.
RESULTS: The incidence of AC gas bubbles was 1.6% (22 out of 1378 eyes). The median WTW in the AC bubbles group was 11.5 mm (range 11.1-12.1), which was significantly different from the control group (11.7 mm, range 10.5-12.8, P=0.021). The result of the median WTW minus the flap diameter in the AC bubbles group was 2.5 mm (range 2.1-3.2), which was statistically different to the control group (2.7 mm, range 1.5-3.8, P=0.008). The logistic regression analysis showed that the result of the WTW minus the flap diameter in the AC bubbles group had an adjusted odds ratio of 0.204 (95%CI; 0.056-0.747, P=0.016).
CONCLUSION: Development of AC gas bubbles during FS flap creation is not an uncommon event in Asian eyes which typically have a small WTW. The flap diameter when adjusted relatively to the WTW is a predisposing factor to the possibility of AC gas bubbles occurrence.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Muanploy Niparugs, Sumet Supalaset, Chulaluck Tangmonkongvoragul, Napaporn Tananuvat, Winai Chaidaroon and Somsanguan Ausayakhun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Muanploy Niparugs, Sumet Supalaset, Chulaluck Tangmonkongvoragul, Napaporn Tananuvat, Winai Chaidaroon and Somsanguan Ausayakhun</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200822]]></guid><cfi:id>49</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes of lactate dehydrogenase in corneal edema after cataract surgery treated with trans-corneal oxygenation therapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200719]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the changes in levels of the lactate dehydrogenase (LDH) enzyme in corneal edema after cataract surgery with trans-corneal oxygenation therapy.
METHODS: This pre-post design study design conducted on 15 patients with corneal edema after cataract surgery and receiving trans-corneal oxygenation therapy. Tear sample (using Schirmer paper, from the inferior fornix of the conjunctiva) was carried out prior to trans-corneal oxygenation therapy, on the day 2 (D2) and day 5 (D5) postoperatively before and after trans-corneal oxygenation therapy. Visual acuity [VA (LogMAR)], corneal endothelial density, central corneal thickness (CCT), and coefficient of variation corneal endothelial (CoV) were recorded. The value of LDH was measured using ELISA. The difference in mean LDH value before and after trans-corneal oxygenation therapy, between two groups were analyzed using Wilcoxon signed rank test.
RESULTS: There was a decrease in LDH tear concentration at D2 (pre vs post: 1127.54±497.09 vs 696.91±489.49; P=0.002) and D5 (pre vs post: 1064.17±677.77 vs 780.28±428.95; P=0.027) after trans-corneal oxygenation therapy as well as decrease in LDH concentration on the D2 compared to D5 (P=0.041). The mean CCT was decreased significantly after the administration of trans-corneal oxygenation (pre vs post: 632.10±25.66 vs 563.90±51.54; P=0.005). The mean VA and CoV increased significantly after the administration of trans-corneal oxygenation (P=0.001 and P=0.028, respectively). However, there was no difference in mean of corneal endothelial density (P=0.814).
CONCLUSION: Trans-corneal oxygenation therapy is associated with significant decrease of tears LDH levels in post cataract surgery with corneal edema. It is accompanied by clinical improvement such as significant reduction of CCT.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Eunike Amelina Lahagu, Jajah Fachiroh, Andreas Surya Anugrah, Wasisdi Gunawan, Indra Tri Mahayana and Suhardjo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eunike Amelina Lahagu, Jajah Fachiroh, Andreas Surya Anugrah, Wasisdi Gunawan, Indra Tri Mahayana and Suhardjo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200719]]></guid><cfi:id>48</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Simple transscleral fixation of IOL technique without tying up haptics]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200720]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce a novel technique for transscleral fixation of the posterior chamber intraocular lens (PC-IOL) that requires no sutures on the IOL haptics.
METHODS: Instead of suturing polypropylene onto the IOL haptics, the method simply winds the thread on the haptics. Fifteen eyes of 15 patients underwent this technique and were followed up for more than 18mo. Surgical outcomes and post-operative complications were evaluated and compared with those of the conventional transscleral fixation method.
RESULTS: Postoperative cylinder was significantly lower in the thread winding group than in the conventional transscleral fixation method group (-1.02±0.46 diopters vs -1.57±0.77 diopters; P=0.01). Further, no postoperative complications, such as optic capture, IOL dislocation, and hyphema, were detected in the thread winding group.
CONCLUSION: We believe that our thread winding technique is better than previously reported methods because it is simple, mechanically stable, and free from suture-related complications.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Junsung Lee, Jae-Yong Jang and Yong-Sok Ji]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Junsung Lee, Jae-Yong Jang and Yong-Sok Ji</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200720]]></guid><cfi:id>47</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical management of non-syndromic ectopia lentis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200721]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare whether aphakic contact lenses or secondary iris-claw intraocular lenses are superior in the refractive management post-pars plana vitreolensectomy in a pedigree with an FBN1 mutation causing non-syndromic ectopia lentis (NSEL) with retinal detachment (RD).
METHODS: Eight affected individuals had pars plana vitreolensectomy for bilateral ectopia lentis (EL). Twelve eyes of 6 patients had secondary iris-claw intraocular lenses inserted and 4 eyes of 2 patients were managed with contact lenses. Rhegmatogenous retinal detachment (RRD) was treated when necessary. Pre- and post-operative assessment included visual acuity, endothelial cell count and dilated fundal examination.
RESULTS: Macula-on RRD was present in all individuals >18y, 64% (7/11 eyes) presenting post-vitreolensectomy with 57% having bilateral non-synchronous RRD. Surgical aphakia was managed with iris-fixated intraocular lenses (IOL group, n=6), or contact lenses (CL group, n=2). Visual acuity ≥0.3 logMAR (driving standard) was achieved in 75% of IOL group eyes and 25% of the CL group eyes. Mean loss of corneal endothelial cell count in the IOL group was 4% at 2y post-operative.
CONCLUSION: In this cohort, refractive management with iris-claw IOLs provided superior outcomes to contact lenses and the authors recommend this as the optimal refractive correction in EL patients.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Kirk AJ Stephenson, Michael O'Keefe and David J Keegan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kirk AJ Stephenson, Michael O'Keefe and David J Keegan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200721]]></guid><cfi:id>46</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical efficacy of Ahmed glaucoma valve implantation combined with 23-gauge vitrectomy for medically uncontrolled neovascular glaucoma with proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200520]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical results of combined Ahmed valve implantation and 23-gauge vitrectomy for medically uncontrolled neovascular glaucoma (NVG) secondary to proliferative diabetic retinopathy (PDR).
METHODS: The medical records of medically uncontrolled NVG patients with PDR who underwent Ahmed valve implantation and 23-gauge vitrectomy between March 2016 and December 2018 were reviewed. Enrolled patients had at least 6-month follow-up. Panretinal photocoagulation (PRP), anti-vascular endothelial growth factor, surgery and medication history were documented.
RESULTS: Eleven eyes of 11 patients were included in our study. The visual acuity improved in 8 eyes and remained unchanged in 3 eyes. The preoperative intraocular pressure (IOP) was significantly decreased at the last follow-up (48.8±4.3 to 17.0±1.5 mm Hg, P<0.001). All eyes needed three topical anti-glaucomatous medications before surgery, but the number was significantly reduced to 0.72±0.19 at the last visit (P<0.001). Four eyes had choroidal detachment and 3 eyes had minor hyphemia, all of which gradually resolved without treatments in one week.
CONCLUSION: Ahmed glaucoma valve implantation combined with 23-gauge vitrectomy might be a safe and alternative treatment for NVG with PDR.]]></description>
<pubDate>2020/4/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Zhong-Jing Lin, Zheng-Hua Chen, Shou-Yue Huang, Jun Sun, Xi Shen and Yi-Sheng Zhong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhong-Jing Lin, Zheng-Hua Chen, Shou-Yue Huang, Jun Sun, Xi Shen and Yi-Sheng Zhong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200520]]></guid><cfi:id>45</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of axis alignment and refractive results of toric phakic IOL using image-guided system]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200421]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate accuracy of axis alignment and refractive results of toric phakic intraocular lens (IOL) implantation using a digital imaging system.
METHODS: This retrospective study investigated toric implantable collamer lens (ICL) implantation in 30 eyes of 21 patients with myopic astigmatism more than 2.0 D guided with digital imaging system. Data were collected during the first week after phakic IOL implantation.
RESULTS: Thirty eyes of 21 patients were included in our study. Patients includes 9 males and 12 females. The mean age of the patients was 26.5±7.1 (range 21-44)y. The mean preoperative manifest astigmatism was 3.2±1.7 (range from 2.25 to 4.75) D. The mean postoperative uncorrected distance visual acuity (UCDVA) were 0.07±0.07 (range from 0.1 to 0.0) logMAR. The mean postoperative residual refractive cylinder was 0.25±0.29 (range 0-0.75) D. Eyes with postoperative residual refractive cylinder of 0.5 D or less represented 80% (24 eyes). The mean postoperative toric IOL misalignment measured by the OPD scan III was 1.9°±1.45° (range from 0 to 5°).
CONCLUSION: Image guided system allows accurate alignment of toric ICL. This is associated with good postoperative visual acuity and low residual refractive astigmatism which correlates with the precision of toric phakic IOL alignment.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Sherif Emerah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sherif Emerah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200421]]></guid><cfi:id>44</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Exome sequencing analysis identifies novel homozygous mutation in ABCA4 in a Chinese family with Stargardt disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200422]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the disease-associated mutations in a Chinese Stargardt disease (STGD) family, extend the existing spectrum of disease-causing mutations and further define the genotype-phenotype correlations.
METHODS: A Chinese STGD family and 200 normal controls were collected. Whole exome sequencing (WES) and bioinformatics analysis were performed to find the pathogenic gene mutation. Physico-chemical parameters of mutant and wildtype proteins were computed by ProtParam tool. Domains analysis was performed by SMART online software. HOPE online software was used to analyze the structural effects of mutation. Immunofluorescence, quantitative real-time polymerase chain reaction and Western blotting were used for expression analysis.
RESULTS: Using WES, a novel homozygous mutation (NM_000350: c.G3190C, p.G1064R) in ABCA4 gene was identified. This mutation showed co-segregation with phenotype in this family. It was not found in the 200 unrelated health controls and absent from any databases. It was considered “Deleterious” as predicted by five function prediction softwares, and was highly conserved during evolution. ABCA4 was expressed highly in the human eye and mouse retina. The p.G1064R was located in AAA domain, may force the local backbone into an incorrect conformation, disturb the local structure, and reduce the activity of ATPase resulting in the disease pathology.
CONCLUSION: We define a novel pathogenic mutation (c.G3190C of ABCA4) of STGD. This extends the existing spectrum of disease-causing mutations and further defines the genotype-phenotype correlations.]]></description>
<pubDate>2020/3/31 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Xiao-Dan Hao, Ying Liu, Bao-Wei Li, Wei Wu and Xiao-Wen Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Dan Hao, Ying Liu, Bao-Wei Li, Wei Wu and Xiao-Wen Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200422]]></guid><cfi:id>43</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ophthalmic photographer virtual clinics in medical retina]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200423]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine whether ophthalmic photographers (OPs) can conduct virtual clinics (VCs) in medical retina appropriately and whether this increases clinic capacity.
METHODS: Three OPs underwent a training programme to learn how to assess and manage macular edema secondary to diabetes or retinal vein occlusion. The 300 consecutive patients over a 7-month observation period in 2018 were assessed in VCs by both OPs and medical retina consultants. The degree of agreement in treatment decisions between doctors and photographers, as well as adverse events, was recorded. The change in number of patients seen in VCs over two years was also measured.
RESULTS: There was 100% agreement in management decisions between doctors and photographers during the 300-patient observation period. No adverse events were recorded. In 2017, 572 patients were seen in VCs by doctors. After OP clinics were introduced in 2018, this number increased by 24% to 709 patients seen by both photographers and doctors. There was a significant increase in mean number of patients seen per month between 2017 (47.7±11.7) and 2018 (59.1±14.4; P=0.045, 95%CI -22.5 to -0.296).
CONCLUSION: OPs can manage certain medical retina patients in VCs appropriately and can increase clinic capacity significantly for particular conditions.]]></description>
<pubDate>2020/3/31 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Abdul R El-Khayat, Rossella Anzidei and Vasileios Konidaris]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdul R El-Khayat, Rossella Anzidei and Vasileios Konidaris</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200423]]></guid><cfi:id>42</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anterior segment optical coherence tomography-guided transepithelial phototherapeutic keratectomy for scarring of the central cornea following pterygium excision]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200320]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the outcomes of patients undergoing anterior segment optical coherence tomography-guided transepithelial phototherapeutic keratectomy (ASOCT T-PTK) for central corneal scarring after pterygium excision.
METHODS: The charts of 11 eyes of 10 patients that underwent ASOCT T-PTK following excision of visual axis-involving pterygia were retrospectively reviewed from a single private practice institution. The visual outcomes and corneal topographic findings were evaluated 4±1mo after pterygium excision and 6±2mo after transepithelial phototherapeutic keratectomy (T-PTK).
RESULTS: All 11 eyes tolerated both the pterygium excision and T-PTK procedure well without any significant intraoperative or postoperative complications. Uncorrected distance visual acuity (UDVA) and manifest refraction corrected distance visual acuity (CDVA) improved after pterygium excision (P=0.03 and P=0.05, respectively). The UDVA and CDVA improved further after T-PTK (P=0.004 and P=0.002, respectively). The topographic surface asymmetry index, topographic surface regularity index, and topographic projected visual acuity significantly improved after T-PTK (P=0.0092, P=0.0022, and P=0.0002, respectively). None of the subjects lost any lines of CDVA, developed recurrence of pterygia or required keratoplasty during the postoperative period.
CONCLUSION: ASOCT T-PTK can provide excellent visual and anatomic outcomes in patients with central corneal scarring after excision of visual axis-involving pterygia.]]></description>
<pubDate>2020/2/4 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Sloan W. Rush and Ryan B. Rush]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sloan W. Rush and Ryan B. Rush</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200320]]></guid><cfi:id>41</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of brimonidine tartrate on basophil activation in glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200321]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the mechanism of which brimonidine tartrate 0.15% causes clinical hypersensitivity.
METHODS: A prospective case-control study comparing 8 glaucoma patients with clinical hypersensitivity to brimonidine to a control group consisting 13 healthy volunteers. Blood samples were stimulated with brimonidine 0.15%, timolol 0.5% or brimonidine tartrate/timolol maleate 0.2%/0.5%. Premixed antibodies (CD63/FITC and aIgE/PE) were added for direct staining and whole-blood samples were lysed, ?xed and analyzed by a flow cytometer. The basophil population was defined by high IgE cell expression. Degranulation was identified by the expression of the activation molecule CD63.
RESULTS: Basophil activation was not significant when comparing percent of activated basophils of patients and healthy controls after exposure to brimonidine (2.58%, 2.45%, respectively, P=0.72). There was a significant suppression of basophil activation when a combination of brimonidine-timolol (0.87%) was compared to timolol (2.27%; P=0.012) and to brimonidine alone (2.58%; P=0.017).
CONCLUSION: The results of our study do not support the hypothesis that brimonidine induces an immediate allergic reaction. Basophil activation was suppressed by the presence of β-blockers in patients hypersensitive to brimonidine and in healthy individuals. This finding indicates that timolol suppress brimonidine drug reaction by a different mechanism.]]></description>
<pubDate>2020/2/4 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Eldar Rosenfeld, Dana Barequet, Gilad Rabina, Sheila Langier, Moshe Lazar, Gabi Shemesh, Shimon Kurtz and Shmuel Kivity]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eldar Rosenfeld, Dana Barequet, Gilad Rabina, Sheila Langier, Moshe Lazar, Gabi Shemesh, Shimon Kurtz and Shmuel Kivity</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200321]]></guid><cfi:id>40</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal hemangioma in Sturge-Weber syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200322]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal hemangioma (DCH) in Sturge-Weber syndrome (SWS).
METHODS: A total of 8 patients with DCH in SWS managed with plaque brachytherapy were retrospectively included. Patients were treated with ruthenium-106 plaque therapy (median apex dose: 83 Gy) at the thickest tumor region. On follow-up, we recorded the tumor thickness, the best-corrected visual acuity (BCVA), subretinal fluid (SRF) status, and complications following treatment.
RESULTS: At a median follow-up of 43mo, tumor regression was observed in all cases, with a complete resolution of SRF and reduction in tumor-thickness. No radiation complications were recorded during the follow up time.
CONCLUSION: Ruthenium-106 plaque therapy to the thickest portion of the tumor seems to be a useful treatment in patients with DCH in SWS.]]></description>
<pubDate>2020/2/4 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ying-Ying Yu, Xiao-Xin Li and Jian-Hong Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Ying Yu, Xiao-Xin Li and Jian-Hong Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200322]]></guid><cfi:id>39</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Modified thin manual Descemet stripping endothelial keratoplasty with air-guided, non-pachymetric donor lenticule dissection: outcomes of graft thickness and complication rate]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200219]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe a modified technique of donor lenticule dissection for thin manual Descemet stripping endothelial keratoplasty (TM-DSEK).
METHODS: Donor material was soaked in balanced salt solution (BSS) for 30min, before being mounted on an artificial anterior chamber (AAC). Rather than BSS, the AAC was filled with filtered air, resulting in a visible reflection at the corneal endothelium-air interface. This reflection served as a landmark for the depth of the dissection, facilitating the creation of a thin lenticule with low risk of perforation. Dissection was commenced at a standardized depth of 500 microns, with no initial pachymetry necessary. Totally 29 donor corneas were dissected by a novice TM-DSEK surgeon. Dissection time, central graft thickness at 2mo and complications were analysed.
RESULTS: Results were similar to other endothelial keratoplasty techniques, despite the cases being performed by a novice DSEK surgeon. Mean dissection time was 7min (range 6-10). One graft perforation occurred (3.45%), but the air tamponaded the break and enabled dissection to be restarted and completed from a different location. Mean central graft thickness after at least two months follow-up was 106 microns (range 25-170).
CONCLUSION: A problem with manual DSEK is the risk of graft perforation by attempting to dissect too thin a lenticule, or creating a thick graft due to fear of perforating. This modified air-guided technique addresses this problem, and is recommended for surgeons either embarking on the learning curve, or who wish to achieve more consistently thin grafts while reducing perforation rates.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Abdo Karim Tourkmani, Andrew M J Turnbull, Parwez N Hossain, Aristides Konstantopoulos and David F Anderson]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdo Karim Tourkmani, Andrew M J Turnbull, Parwez N Hossain, Aristides Konstantopoulos and David F Anderson</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200219]]></guid><cfi:id>38</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A modified method for suprachoroidal fluid drainage in kissing choroidal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200220]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce a new method for suprachoroidal fluid drainage before 23-gauge pars plana vitrectomy.
METHODS: A 15o side-port blade was firstly used to create a sclerotomy into the suprachoroidal space for initial drainage. A 30-guage needle was then applied to inject balanced saline solution through the existing sclerotomy for further drainage. After most of the suprachoroidal fluid was drained, standard 3-port 23-guage pars plana vitrectomy was performed.
RESULTS: We have succeeded in using this technique to treat five patients with retinal detachment and kissing choroidal detachment (KCD). The choroidal detachment was visibly recessed in all cases after drainage with no intraoperative complications. After removal of silicon oil at 3mo follow-up, all patients obtained a reattached retina. No postoperative complications such as hypotony and endophthalmitis occurred.
CONCLUSION: The new technique is efficient and safe for suprachoroidal fluid drainage for patients with rhegmatogenous retinal detachment. In future, further larger series are needed to attest to its safety and ef?cacy.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Zi-Zhong Hu, Qing-Huai Liu, Yu-Zhi Ding, Yun Su and Jiang-Dong Ji]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zi-Zhong Hu, Qing-Huai Liu, Yu-Zhi Ding, Yun Su and Jiang-Dong Ji</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200220]]></guid><cfi:id>37</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diagnosis and surgical management of isolated inferior oblique palsy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200221]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the etiology, clinical characteristics, surgical options and surgical outcomes of isolated inferior oblique palsy (IOP).
METHODS: A retrospective review was performed on patients with isolated IOP who were seen between January 2010 and June 2017. The following clinical data were obtained from the patients’ charts: visual acuity, ocular alignment, ocular motility, cyclotorsion, stereoacuity, Parks three-step test, surgical methods, surgical outcomes and complications. Surgical success was defined as horizontal deviation ≤10 prism diopters (PD) and a vertical deviation ≤5 PD in primary gaze at both near and distant vision as assessed at last follow-up.
RESULTS: The records from a total of 18 patients (8 males and 10 females) with an average age of 27.56y were included in this study. The right eye was affected in 11 patients, the left in 6 patients and both eyes in 1 patient. Twelve cases (66.7%) were congenital and 6 (33.3%) were acquired IOP. The 6 acquired cases involved 2 resulting from orbital trauma/surgery, 2 from midbrain microvascular ischemia, 1 from myasthenia gravis and 1 of unknown etiology. Strabismus surgery was performed in 13 cases. Surgical techniques included weakening of superior oblique and vertical rectus recession and resection. After a mean follow-up of 15.11mo, the corrected vertical deviation in primary position was 19.92±8.52 PD (P=0.000) and the corrected horizontal deviation was 14.31±12.68 PD (P=0.002). The surgical success rate was 61.5% and no surgical complications were present.
CONCLUSION: Isolated IOP represents a rare condition, with most cases (66.7%) involving a congenital basis. The acquired cases included vascular, orbital trauma/surgery and myasthenia gravis. Weakening of the ipsilateral superior oblique muscle and/or contralateral superior rectus recession often resulted in favorable surgical outcomes with a surgical success rate of 61.5%.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Xiao-Fei Wu and Jian-Hua Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Fei Wu and Jian-Hua Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200221]]></guid><cfi:id>36</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Proteome alterations in aqueous humour of primary open angle glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200124]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To unravel the primary open angle glaucoma (POAG) related proteomic changes in aqueous humour (AH).
METHODS: Totally 35 patients listed for cataract surgery (controls: n=12, age: 67.4±13.6y) or trabeculectomy for POAG (n=23, age: 72.5±8.3y) were included. AH samples of those patients were obtained during cataract surgery or trabeculectomy. AH samples were subsequently pooled into the experimental groups under equal contribution in terms of protein amount of each individual patient. Protein samples were analyzed by a linear trap quadrupol Orbitrap Mass Spectrometry device with an upstream liquid chromatography system. The obtained raw data were analyzed using the Maxquant proteome software and compared. Proteins with a fold-change ratio higher than a cut-off of 2 were considered as noticeably altered.
RESULTS: A total number of 175 proteins could be identified out of the AH from POAG and cataract by means of quantitative mass spectrometric analysis. Apolipoprotein D (fold change, 3.16 times), complement C3 (2.96), pigment epithelium-derived factor (2.86), dickkopf-related protein 3 (2.18) and wingless-related integration (Wnt) inhibitory factor 1 (2.35) were significantly upregulated within the AH of glaucoma compared to cataract serving as controls.
CONCLUSION: AH provides a tool to analyze changes in glaucoma and shows striking changes in Wnt signaling inhibitory molecules and other proteins.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Hanhan Liu, Fabian Anders, Sebastian Funke, Karl Mercieca, Franz Grus and Verena Prokosch]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hanhan Liu, Fabian Anders, Sebastian Funke, Karl Mercieca, Franz Grus and Verena Prokosch</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200124]]></guid><cfi:id>35</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcomes of management of posterior capsule rupture with air bubble techniques]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201224]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce a new surgical technique, air-bubble technique for the management of posterior capsule rupture (PCR) and to evaluate the safety and efficacy of the technique.
METHODS: A retrospective case series analysis of 24 eyes of 24 patients, in which the air bubble technique was used for the management of PCR, was performed. Once PCR occurred, a dispersive ophthalmic viscosurgical device (OVD) was injected into the tear. And small volumes (0.2-0.3 mL) of air bubbles were injected beneath the OVD. The air bubble served as a physical barrier and supported the posterior capsule.
RESULTS: After surgery, none of the patients had serious complications during the follow-up period of 1y. Extension of the PCR size occurred in only 2 cases, and additional OVD injection was required only in 3 cases. Air bubbles imparted great stability to the nuclear pieces and the posterior capsule.
CONCLUSION: The air-bubble technique may be considered a safe and effective procedure for managing a PCR. It may be of value to the inexperienced cataract surgeon.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jongyeop Park, Seungwoo Lee and Jinhyun Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jongyeop Park, Seungwoo Lee and Jinhyun Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201224]]></guid><cfi:id>34</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prevalence of meibomian gland dysfunction in staffs and faculty members of a Chinese university]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201023]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the prevalence of meibomian gland dysfunction (MGD) in staffs and faculty members of Sichuan University, China.
METHODS: The records of the annually systemic physical examination of 4404 consecutive staffs and faculty members of Sichuan University were analyzed retrospectively. Ocular symptoms and signs of ocular surface were evaluated.
RESULTS: MGD was diagnosed in 1424 participants (32.3%), with a mean age of 43.0±9.6y. Of these, 718 (50.4%) were females and no significant difference was found between males and females. The highest prevalence was found in the age 50-59y (36.0%). Logistic regression analysis showed that age is an impact factor of MGD (P<0.001, odds ratio=1.014).
CONCLUSION: The prevalence of MGD in staffs and faculty members of a Chinese university is 32.3%, and increases with age.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jing-Ge Gao, Jun Chen, Yan Tang and Da-Nian Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Ge Gao, Jun Chen, Yan Tang and Da-Nian Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201023]]></guid><cfi:id>33</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Primary rhegmatogenous retinal detachment: evaluation of a minimally restricted face-down positioning after pars plana vitrectomy and gas tamponade]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210621]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and efficacy of a minimally restricted face-down postoperative positioning following pars plana vitrectomy (PPV) with gas tamponade for primary rhegmatogenous retinal detachment (RRD).
METHODS: Patients with primary RRD treated with PPV and gas tamponade and followed up for at least 6mo were selected for the study. All phakic eyes underwent simultaneous cataract surgery. The patients were required to be in a postoperative position that prevented downward flow of retinal tears. Patients with macular detachment were positioned face-down for only a couple of hours. The patients were assessed for preoperative and postoperative best-corrected visual acuity (BCVA), anatomical retinal reattachment rate, and postoperative complications.
RESULTS: In total, 40 eyes of 39 patients with primary RRD were included in the study. A single tear was present in 30 eyes (75.0%), multiple retinal tears were present in nine eyes (22.5%), and oral dialysis was present in one eye (2.5%). The anatomical success rate was 90.0% (36 cases) after the primary surgery, and the final anatomical success rate was 100%. The BCVA improved significantly (P<0.001) from 0.75 logarithm angle of resolution (logMAR) preoperatively to 0.12 logMAR at the final visit. Postoperative complications included intraocular pressure elevation (≥25 mm Hg) in 11 patients (27.5%), fibrin formation in two patients (5.0%), pupillary capture of the intraocular lens in two patients (5.0%), and posterior synechia in one patient (2.5%).
CONCLUSION: A minimally restricted face-down and flexible postoperative positioning after PPV and gas tamponade for primary RRD is effective and safe.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Kiichiro Kusaba, Kotaro Tsuboi, Tsuneaki Handa, Yukihiko Shiraki, Takuya Kataoka and Motohiro Kmaei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kiichiro Kusaba, Kotaro Tsuboi, Tsuneaki Handa, Yukihiko Shiraki, Takuya Kataoka and Motohiro Kmaei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210621]]></guid><cfi:id>32</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Via pars plana anterior iris enclavation IOL fixation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210520]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe a via pars plana anterior iris enclavation intraocular lens (IOL) fixation technique
METHODS: A total of 35 consecutive aphakic vitrectomised patients (average age 71.12±10.12y) underwent pars plana vitrectomy (PPV) and via pars plana anterior iris enclavation IOL fixation.
RESULTS: The mean preoperative best corrected visual acuity (BCVA) was 0.11±0.14 logMAR, the mean postoperative BCVA was 0.07±0.11 logMAR. The preoperative mean spherical equivalent was 7.22±4.21 D. The final mean spherical equivalent was -0.25±0.15 D. No eyes had hypotony, retinal or choroidal detachment or endophthalmitis.
CONCLUSION: This technique may be a safe and useful in the case of aphakia, and a prospective study would be useful to confirm this findings.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Tomaso Caporossi, Ruggero Tartaro, Giancarlo Albani, Francesco Barca, Fabrizio Giansanti and Stanislao Rizzo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tomaso Caporossi, Ruggero Tartaro, Giancarlo Albani, Francesco Barca, Fabrizio Giansanti and Stanislao Rizzo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210520]]></guid><cfi:id>31</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A simple new technique for the induction of residual posterior vitreous cortex removal and membrane peeling]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210421]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe a quick, cost-effective alternative to using a scraper to remove the residual posterior vitreous cortex and create an inner limiting membrane (ILM) flap during vitrectomy.
METHODS: The surgical technique and a retrospective interventional single-center series of cases were described. A hook was made on the tip of a conventional syringe needle (outer diameter, 0.6 mm; 23 gauge) by bending the needle against a plate. We used this hook to remove the residual posterior vitreous cortex and create an ILM flap during vitrectomy. The efficacy and safety of using this instrument in ophthalmological procedures for a variety of vitreoretinal disorders were evaluated.
RESULTS: The hook was effective for removing focal or diffuse residual posterior vitreous cortex in eyes with rhegmatogenous retinal detachment, proliferative diabetic retinopathy, and pathological myopia. It was also successfully used to make a free edge of the ILM and help strip the epiretinal membrane. There were no serious complications associated with using the hook in delicate ophthalmological procedures.
CONCLUSION: The hook, made by bending a conventional needle, is a simple and cost-effective instrument for removing residual posterior vitreous vortex and to create epiretinal and ILM flaps during vitrectomy in eyes with various vitreoretinal diseases.]]></description>
<pubDate>2021/2/25 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Wen-Yi Tang, Ting Zhang, Ke-Yan Wang, Qing Chang, Xin Huang and Ge-Zhi Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Yi Tang, Ting Zhang, Ke-Yan Wang, Qing Chang, Xin Huang and Ge-Zhi Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210421]]></guid><cfi:id>30</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intracameral anti-VEGF injection for advanced neovascular glaucoma after vitrectomy with silicone oil tamponade]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210320]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of intracameral injection of conbercept for the treatment of advanced neovascular glaucoma (NVG) after vitrectomy with silicone oil tamponade.METHODS: Conbercept 0.5 mg/0.05 mL was injected into the anterior chamber of 5 eyes, which had developed advanced NVG after vitrectomy with silicone oil tamponade. Then, trabeculectomy with mitomycin C and pan-retinal photocoagulation (PRP) or extra-PRP were conducted within 2d. The follow-up time was 6mo. Best-corrected visual acuity (BCVA), intraocular pressure (IOP), neovascularization of iris (NVI) were recorded before and after treatment.RESULTS: Within 2d after injection, IOP control, and NVI regression were optimal for trabeculectomy. Hyphema occurred in one eye in the process of injection. But none of them present hyphema after trabeculectomy. At the end of follow-up time, all eyes had improved BCVA, well-controlled IOP, and completely regressed NVI.CONCLUSION: Intracameral injection of conbercept is safe and effective in the treatment of patients with advanced NVG after vitrectomy with silicone oil tamponade. Within 2d after injection is the optimal time window for trabeculectomy, which can maximally reduce the risk of perioperative hyphema.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ling Bai, Farheen Tariq, Yi-Dan He, Shu Zhang and Feng Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ling Bai, Farheen Tariq, Yi-Dan He, Shu Zhang and Feng Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210320]]></guid><cfi:id>29</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical observations of acute onset of myopic optic neuropathy in a real-world setting]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210321]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical features of acute myopic onset of optic neuropathy and observe the effects of retrobulbar and systemic glucocorticoid therapy in a real-world setting.METHODS: A retrospective observational case series included 18 patients with a clinical diagnosis of acute onset of myopic optic neuropathy in a real-world setting. While the patients were using retrobulbar and systemic glucocorticoid therapy, various imaging examination data were analysed, and the clinical features of myopic optic neuropathy were summarized for 6mo to 2y.RESULTS: The included group of patients with acute onset of myopic optic neuropathy consisted mostly of females (n=11). The visual field (VF) showed abnormalities in bilateral eyes, including the spread of physiological blind spots, central and paracentral dark spots, and centripetal peripheral VF reduction; but central vision with no subjective changes. The visual evoked potential (VEP) was abnormal in all eyes with vision loss. The best corrected visual acuity (BCVA) was improved from 1.04±0.63 to 0.47±0.57 (logMAR) after glucocorticoid treatment (P<0.05). In patients with a short course (within 1wk), recovery was fast and achieved the same BCVA as recorded before the onset within 6d. However, in patients with the long course (1 to 2wk), recovery was slow and did not achieve the BCVA recorded before the onset within 10d. The changes of intraocular pressure (IOP) were not obvious before and after treatment (18.68±5.30 vs 19.55±5.34 mm Hg, P>0.05). There was no recurrence during long-term follow-up observation.CONCLUSION: The acute onset of myopic optic neuropathy is characterized by BCVA and VF abnormalities in bilateral eyes. Retrobulbar and systemic glucocorticoid therapy is effective.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Li Liao, Rui Fang, Fang Fang and Xiao-Hua Zhu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li Liao, Rui Fang, Fang Fang and Xiao-Hua Zhu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210321]]></guid><cfi:id>28</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Utilizing dexamethasone intravitreal implant to control postoperative inflammation in refractory uveitis undergoing cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210221]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the effectiveness of intravitreal implantation of dexamethasone implant (Ozurdex) after phacoemulsification and intraocular lens implantation in refractory uveitis patients.
METHODS: This single-center retrospective study conducted for refractory pan-uveitis patients who underwent cataract surgery combined with intravitreal Ozurdex implantation. The main outcome measurements were best-corrected visual acuity (BCVA), central retinal thickness (CRT), grade of anterior chamber cell (AAC), intraocular pressure (IOP), and systemic/ocular adverse events.
RESULTS: Ten eyes of 7 patients were included. BCVA showed significant improvement at 1mo (P=0.004), 3mo (P=0.0004), and 6mo (P=0.001) post operation. There were no statistically significant differences in the postoperative CRT among follow-up groups (P>0.05). No significant differences were observed in the baseline IOP when compared to 1, 3, and 6mo (all P>0.05) post operation. One patient developed a transient elevated IOP post injection. Two eyes (20%) developed posterior capsular opacifications and underwent neodymium-doped yttrium aluminum garnet (Nd:YAG) laser capsulotomy. In six patients (8 eyes, 71.4%), the systemic steroid usage was reduced to below 10 mg/d. The patients experienced a mean of 1.4±0.52 recurrences of inflammation in the 6mo before operation and 0.7±0.48 in the 6mon post operation. The mean recurrence time was 13±0.58wk (range 12-14wk) post operation. In five of seven patients (7 out of 10 eyes), inflammation relapse was developed postoperatively. Only one patient (2 eyes) needed increased amounts of oral corticosteroids. Intraocular inflammation recurrence in the remaining patients was controlled by topical steroids.
CONCLUSION: Ozurdex is considered a safe and effective approach to control postoperative inflammation in cataract surgery for patients with refractory uveitis in our study. After the disappearance of Ozurdex’s anti-inflammatory effects over time, in most cases the recurrent inflammation can be controlled by topical steroids.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Yong-Tao Li, Xue-Xue Cui, Xiao-Tong Yang, Bing Li, Xin-Jun Ren, Xiao-Rong Li and Xiao-Min Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong-Tao Li, Xue-Xue Cui, Xiao-Tong Yang, Bing Li, Xin-Jun Ren, Xiao-Rong Li and Xiao-Min Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210221]]></guid><cfi:id>27</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Introduction of longstanding complicated sulcus intraocular lens into the intact capsular bag]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211119]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To propose a surgical technique that successfully reopened the empty and intact capsular bag after long periods of closure, with repositioning of the intraocular lens (IOL) from the ciliary sulcus into its preferred habitat inside the capsular bag.
METHODS: This is a case series, prospective, and interventional study. The technique was first performed on an aphakic high myope with a closed posterior capsule for 18y. Afterwards, five patients with recurrently displaced sulcus IOLs for a range of 1mo to 7y were performed for the same technique. During surgery, identifying a “telltale white line” was an important landmark for detecting the site of major adhesions between the edge of the capsulorhexis and the posterior capsule. These adhesions were freed using combined manual and viscoelastic dissection, followed by an easier freeing of adhesions along the whole capsular bag. The IOL was safely implanted, exchanged, or introduced from the sulcus into the fibrotic and closed capsular bag. Patients were followed up for a period ranging from 6 to 17mo postoperatively.
RESULTS: All the patients experienced a remarkable improvement in their subjective refraction. Slit lamp examination showed a postoperative centralized IOL in the bag. The follow up visits confirmed visual and IOL stability.
CONCLUSION: This newly-introduced surgical technique facilitates the reopening of the empty yet intact capsular bag that has been closed by fibrotic proliferations, with secured implantation of the IOL inside the capsular bag. Patients with inadvertent implantation of IOLs into the ciliary sulcus, yet having an intact capsular bag, can benefit from this technique.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Fathy Fawzy Morkos, Nader Fathy Fawzy, Mohamed El Bahrawy and Rania Serag Elkitkat]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fathy Fawzy Morkos, Nader Fathy Fawzy, Mohamed El Bahrawy and Rania Serag Elkitkat</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211119]]></guid><cfi:id>26</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Human umbilical cord-derived mesenchymal stem cells treatment for refractory uveitis: a case series]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211120]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate therapeutic outcomes of human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) treatment in patients with refractory uveitis.
METHODS: A retrospective and noncomparative review was performed on four patients with refractory uveitis from December 2013 to December 2017. HUC-MSCs were administered intravenously at a dose of 1×106 cells/kg. Clinical response, relapse rate, change of visual acuity, and other metrics were evaluated.
RESULTS: All four patients presented with responses to HUC-MSCs treatment, with three males and one female. The numbers of uveitis attacks per year after the HUC-MSCs treatment (0, 2, 0, 0 respectively) all decreased compared with the numbers before the treatment (3, 6, 4, 4 respectively). The oral steroid and immunosuppressive agents were tapered in all patients without recrudescence of ocular inflammation, and three patients discontinued their oral medicine at the last visit. The best corrected visual acuity (BCVA) of 3 patients was improved to varying degrees, and the BCVA of 1 patient remained at 20/20 (Snellen chart) from the first to the last consultation.
CONCLUSION: The study provides an effective therapy of HUC-MSCs in maintaining remission in patients affected by uveitis refractory to previous immunosuppressant treatments.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Jing Yang, Xin-Jun Ren, Xi-Teng Chen, Yuan-Feng Jiang, Zhi-Bo Han, Zhong-Chao Han, Xiao-Rong Li and Xiao-Min Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Yang, Xin-Jun Ren, Xi-Teng Chen, Yuan-Feng Jiang, Zhi-Bo Han, Zhong-Chao Han, Xiao-Rong Li and Xiao-Min Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211120]]></guid><cfi:id>25</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A novel temporary keratoprosthesis technique for vitreoretinal surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211121]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the safety of vitreoretinal surgery when using a soft contact lens as a temporary keratoprosthesis (TKP) in patients with severe corneal opacifications.
METHODS: Three patients with simultaneous corneal and vitreoretinal pathology were treated with a soft contact lens that was used as a TKP to facilitate vitreoretinal surgery. The soft contact lens was fixated with sutures onto the globe so that no leakage was possible.
RESULTS: Vitreoretinal surgery with excellent fundus view was possible in all cases. The soft contact lens allowed safe central and peripheral vitrectomy. Surgery was successful in all cases.
CONCLUSION: A soft contact lens properly fixated on the globe can successfully replace a TKP. This surgical procedure has several advantages like one size fits all, low costs, and easy access to the material.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Christos Skevas, Eileen Bigdon, Alexander Steinhorst, Toam Katz, Philipp Schindler, Robert Kromer and Martin Stephan Spitzer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Christos Skevas, Eileen Bigdon, Alexander Steinhorst, Toam Katz, Philipp Schindler, Robert Kromer and Martin Stephan Spitzer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211121]]></guid><cfi:id>24</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Congenital dysplasia involving both medial and inferior recti: clinical features and surgical outcomes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211022]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical features and surgical outcomes of congenital dysplasia involving both inferior recti (IR) and medial recti (MR) muscles.
METHODS: A retrospective review was conducted including cases of simultaneous congenital dysplasia of IR and MR that were diagnosed and surgically treated at the Zhongshan Ophthalmic Center, Sun Yat-sen University, China, from July 2009 to November 2019. Ocular motility, ocular alignment at distance (6 m) and near (33 cm) by prism alternating cover test and stereoacuity were assessed in all patients before and after surgery.
RESULTS: A total of five patients (four males and one female; three with right eye and two with left eye congenital dysplasia) were included in this review. The patients ranged in age from 10 to 42y (21±13.4y). The main clinical findings were hypertropia and exotropia of the affected eye, along with motility limitations in adduction and depression. Lateral rectus (LR) recession/transposition combined with IR resection was performed in one case. Two scheduled surgeries were performed in four cases, with one involving superior rectus recession and IR resection and the others LR recession and MR resection. Mean±SD pre-surgical exotropia of 51.0±31.11 prism diopter (PD) and hypertropia of 29.20±7.12 PD in the primary position were decreased to 3.6±12.90 and 3.2±10.09 PD, respectively, at two years after surgery, with a success rate of 60% and an under-correction rate of 40%.
CONCLUSION: The main clinical features associated with simultaneous MR/IR congenital dysplasia are hypertropia and exotropia of the affected eye along with motility limitations in adduction and depression. Scheduled two-stage surgeries achieved a success rate of 60%.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Li-Cheng Fu, Bin-Bin Zhu and Jian-Hua Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Cheng Fu, Bin-Bin Zhu and Jian-Hua Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211022]]></guid><cfi:id>23</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Different compression sutures combined with intracameral air injection for acute corneal hydrops]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220918]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of full-thickness sutures combined with intracameral air injection (FTS-AI) versus pre-Descemet’s membrane sutures combined with intracameral air injection (PDS-AI) in the management of acute corneal hydrops in keratoconus.METHODS: The research included 8 patients (8 eyes) suffering from acute corneal hydrops caused by keratoconus. Four patients were randomly assigned to FTS-AI. And the other four were randomly assigned to PDS-AI. Corneal oedema, visual acuity, corneal thickness were assessed during follow-up.RESULTS: The demographics, preoperative duration of symptoms and severity of corneal hydrops between the two groups were not significantly different. The mean corneal oedema resolution time after FTS-AI and PDS-AI were 11±1.15 and 15±1.41d, respectively (P=0.005). The maximum corneal thickness of the scarred region decreased in both groups at one week postoperatively (P<0.05). No obvious difference was found in the mean maximal corneal thickness between the two groups postoperatively. The BCVA improved significantly after FTS-AI and PDS-AI at three months postoperatively. No obvious difference was found in the BCVA after FTS-AI and PDS-AI at three months postoperatively.CONCLUSION: FTS-AI and PDS-AI are safe and effective therapies to accelerate the resolution of corneal oedema in acute corneal hydrops secondary to keratoconus. Despite faster resolution of corneal oedema in the FTS-AI group, we recommend PDS-AI to avoid potential endothelium cell damage.]]></description>
<pubDate>2022/9/1 14:00:54</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Xin Liu, Hua Li, Shen Qu, Qiao Yu, Hui Lin and Yan-Long Bi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin Liu, Hua Li, Shen Qu, Qiao Yu, Hui Lin and Yan-Long Bi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220918]]></guid><cfi:id>22</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[COVID-19 infection with keratitis as the first clinical manifestation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220919]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report a case which keratitis is the first clinical manifestation of COVID-19 that occurred 3d earlier than the common COVID-19 symptoms.METHODS: Regular slit lamp examination, corneal scraping test, and chest computed tomography (CT) were performed for patients with COVID-19 infection. The ophthalmologic treatment included ganciclovir eye drop (50 mg/mL, 6 times/d). The treatment for diarrhea included Guifu Lizhong pills (TID). The antiviral therapy consisted of oseltamivir (75 mg capsule Q12H); therapy preventing bacterial infection consisted of azithromycin (250 mg tablet QD) and moxifloxacin (0.4 g tablet Q12H); and therapy for cough relief and fever prevention consisted of Chinese herbal decoction.RESULTS: A 35-year-old male suddenly suffered pain, photophobia, and tears in his right eye for one day without systemic COVID-19 symptoms. Patient was diagnosed with keratitis, which was seemingly different from common keratitis. Ganciclovir eye drop was initiated. The corneal scraping test for COVID-19 was positive. The chest CT images were abnormal confirming the diagnosis of COVID-19 infection. The antiviral and antibacterial therapies were initiated. Chinese herbal therapy was used for cough relief and fever prevention. After roughly two weeks, patient recovered from COVID-19.CONCLUSION: A new type of keratitis, atypical keratitis, is a clinical manifestation of COVID-19, and this clinical manifestation could appear 3d earlier than fever and cough. The earlier a COVID-19 clinical manifestation is identified, the earlier can a patient be directed to stay at home, and significantly fewer people would be infected.]]></description>
<pubDate>2022/9/1 14:00:55</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Dong-Mei Zuo, Lin-Ping Xue, Heng Fan, Sheng-Li Yang, Liang-Chang Li, Ji-Hong Luo, Shuo Zang and Jun Xiao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dong-Mei Zuo, Lin-Ping Xue, Heng Fan, Sheng-Li Yang, Liang-Chang Li, Ji-Hong Luo, Shuo Zang and Jun Xiao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220919]]></guid><cfi:id>21</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of intravitreal HLX04-O, an anti-VEGF monoclonal antibody, for the treatment of wet age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220920]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of HLX04-O, an investigational ophthalmic formulation of HLX04 (bevacizumab biosimilar) for intravitreal injection, as a treatment for wet age-related macular degeneration (wAMD) in a phase 1/2 clinical trial (NCT04993352).METHODS: Eligible patients with wAMD were enrolled to receive HLX04-O intravitreal injections at a dose of 1.25 mg/0.05 mL every four weeks. Efficacy and adverse events were evaluated every month during study visits.RESULTS: A 76-year-old male with wAMD in his left eye participated in the trial and completed six cycles of HLX04-O intravitreal injections. Changes were observed in macular center point thickness (baseline vs last study visit, 437 vs 255 μm) and best-corrected visual acuity letter score (baseline vs last study visit, 36 vs 77) of the affected eye, which indicated an improvement in wAMD over treatment. No adverse events were reported by the data cutoff date.CONCLUSION: HLX04-O at 1.25 mg/0.05 mL every four weeks is well tolerated in this patient, demonstrating promising safety and efficacy in wAMD treatment. Large-scale studies are required to confirm the outcomes.]]></description>
<pubDate>2022/9/1 14:00:55</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Zhen Zhang, Ying Wu, Ya-Li Lyu, Meng-Qi Chang, Qiu-Jin Xu, Yi-Ming Liu, Wen-Ying Kang, Qing-Yu Wang and Chuan-Ling Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhen Zhang, Ying Wu, Ya-Li Lyu, Meng-Qi Chang, Qiu-Jin Xu, Yi-Ming Liu, Wen-Ying Kang, Qing-Yu Wang and Chuan-Ling Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220920]]></guid><cfi:id>20</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Management of cataract surgery in Lowe syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220722]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the ophthalmic and anesthesiologic management of cataract surgery in children with Lowe syndrome receiving lens removal, the development and management of secondary glaucoma.METHODS: This retrospective case series included 12 eyes of 6 children with genetically verified Lowe syndrome receiving cataract removal. Information regarding the type and duration of surgery and total anesthesia time were recorded. Additionally, intra- and postoperative complications were noted as well as clinical examinations such as visual acuity and funduscopy.RESULTS: All children received simultaneous bilateral cataract surgery at the mean age of 8.98±3.58wk. Lensectomy combined with posterior capsulotomy and anterior vitrectomy was performed in all children. The mean time for cataract surgery per eye was 35.83±8.86min, whereas the total time of surgery was 153.33±22.11min. The mean extubation time and duration at recovery room was 42.33±22.60min and 130.00±64.37min, respectively. During surgery, a decrease of oxygen saturation below 93% was found in only one child. During the postoperative follow-up, nystagmus (6 children) and strabismus (5 children) was commonly found in contrast to no case of visual axis opacification. Secondary glaucoma developed in five eyes of three children, which was treated with topical eye drops in only one child. A trabeculectomy was performed in both eyes of one child, whereas removal of syechia and an iridectomy in one eye of one child.CONCLUSION: Bilateral simultaneous cataract surgery under general anesthesia is a safe surgical procedure in Lowe syndrome children. The glaucoma screening with intraocular pressure measurements is crucial in the postoperative management of Lowe syndrome patients to avoid additional visual impairment.]]></description>
<pubDate>2022/6/30 14:51:27</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Katharina Eibenberger, Sandra Rezar-Dreindl, Franz Pusch, Ursula Schmidt-Erfurth and Eva Stifter]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Katharina Eibenberger, Sandra Rezar-Dreindl, Franz Pusch, Ursula Schmidt-Erfurth and Eva Stifter</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220722]]></guid><cfi:id>19</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Timely vitrectomy without intraocular lens removal for acute endophthalmitis after cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220621]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical features, causative organisms and effects of timely vitrectomy and silicone oil tamponade without intraocular lens (IOL) removal in the treatment of acute-onset endophthalmitis after cataract surgery (APCE).METHODS: We retrospectively analyzed the clinical features and microbiological factors in 10 eyes of 10 patients with APCE at Tianjin Medical University General Hospital from January 2010 to December 2018. Data on the clinical features, causative organisms, visual acuity, intraocular pressure (IOP) and complications were collected. The mean follow-up period was 25.5mo.RESULTS: The mean age of the patients was 71.4y. The mean time between cataract surgery and the onset of endophthalmitis was 2.0d. Preoperative visual acuity ranged from no light perception to hand motion. After vitrectomy, the visual acuity increased in nine eyes (90%), and was unchanged in one eye (10%). A significant difference was observed between the mean preoperative (36.3±7.1 mm Hg) and postoperative IOP (14.9±4.3 mm Hg, P&#x003C;0.05). Staphylococcus epidermidis was isolated in 5 eyes, S. aureus in 2 eyes, and Enterococcus in 1 eye. Postoperative complications mainly included fibrin exudates in the anterior chamber at the early stages in all eyes and temporary IOP elevation in one eye. No retinal detachment or ocular atrophy was observed during the follow-up period.CONCLUSION: Under systemic antibiotic treatment and timely diagnosis, vitrectomy and silicone oil tamponade without IOL removal is a safe and effective method for APCE.]]></description>
<pubDate>2022/5/31 14:47:18</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Hai-Xia Guo, Ruo-Tian Xie, Yun Wang, Cai-Yun You, Yuan-Yuan Liu, Xiang-Da Meng, Jin-Guo Yu and Hua Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Xia Guo, Ruo-Tian Xie, Yun Wang, Cai-Yun You, Yuan-Yuan Liu, Xiang-Da Meng, Jin-Guo Yu and Hua Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220621]]></guid><cfi:id>18</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A novel Nance-Horan syndrome mutation identified by next-generation sequencing in a Chinese family]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220622]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the disease-causing mutation in a four-generation Chinese family diagnosed with Nance-Horan syndrome (NHS).METHODS: A Chinese family, including four affected patients and four healthy siblings, was recruited. All family members received ophthalmic examinations with medical histories provided. Targeted next-generation sequencing approach was conducted on the two affected males to screen for their disease-causing mutations.RESULTS: Two male family members diagnosed with NHS manifested bilateral congenital cataracts microcornea, strabismus and subtle facial and dental abnormalities, while female carriers presented posterior Y-sutural cataracts. A novel frameshift mutation (c.3916_3919del) in the NHS gene was identified. This deletion was predicted to alter the reading frame and generate a premature termination codon after a new reading frame.CONCLUSION: The study discovers a new frameshift mutation in a Chinese family with NHS. The findings broaden the spectrum of NHS mutations that can cause NHS in Chinese patients.]]></description>
<pubDate>2022/5/31 14:47:18</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Hong-Yan Sun, Hong-Jing Zhu, Ru-Xu Sun, Ying Wang, Jia-Nan Wang, Bing Qin, Wei-Wei Zhang and Jiang-Dong Ji]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong-Yan Sun, Hong-Jing Zhu, Ru-Xu Sun, Ying Wang, Jia-Nan Wang, Bing Qin, Wei-Wei Zhang and Jiang-Dong Ji</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220622]]></guid><cfi:id>17</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Five-in-one: a novel, cost-effective yet simple use of micro needle holder]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220420]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To achieve a balance between efficiency and cost in the management of medical instrument by the use of micro needle holder.METHODS: In this study, the novel multifunctional use of micro needle holders was performed between 2018 and 2019 at the Department of Ophthalmology in the 4 hospitals in Shaanxi Province. In this innovation, the micro needle holders were initially used as micro forceps to remove sutures, as eye spud to safety extract foreign body from cornea, as ciliary forceps to remove trichiasis, as well as punctal dilator to dilate most small puncta.RESULTS: Using this technique, the medical costs of both procurement and sterilization were cut off in the selected 4 hospitals. The purchase cost has dropped by roughly 50%. The sterilization cost was decreased by about 30%.CONCLUSION: The innovation in the five-in-one multifunctional use of micro needle holders saves the medical costs.]]></description>
<pubDate>2022/3/29 14:34:19</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ning Gao, Jia-Li Zhu, An-Le Su, Lie-Ling Kou and Zhao Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ning Gao, Jia-Li Zhu, An-Le Su, Lie-Ling Kou and Zhao Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220420]]></guid><cfi:id>16</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Y-splitting medial rectus muscle and recession in treatment for convergence excess esotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220421]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the surgical outcome of medial rectus (MR) recession with Y-splitting procedure in treatment of esotropia with convergence excess.METHODS: Medical records were retrospectively reviewed for those patients who underwent surgical treatment for their convergence excess esotropia (CEET) between January 2018 and December 2020. Refractive error was examined by the equipment of the VS100 (Welch Allyn). The surgical approach was bilateral MR recession with Y-splitting. The amount of recession was calculated according to the deviation angle at distance. Ocular movement and ocular alignment at distance and near were evaluated pre- and post-operatively. Binocular sensory status was evaluated by the Bagolini striated glasses at near and distance, and by stereoacuity assessment at near using the Titmus test.RESULTS: Six patients with CEET were included in this study. Four of them were hyperopia and two of them were myopia. A mean of eso-deviation angle at distance had been changed from 27.3±13.02 prism diopters (PD) preoperatively to 1.83±1.60 PD postoperatively (P<0.05), while a mean of eso-deviation angle at near had been changed from 50.00±20.74 PD preoperatively to 6.83±0.98 PD postoperatively (P<0.05). Patients had obtained binocular vision postoperatively.CONCLUSION: The surgical approach of Y-splitting MR and recession is effective in treatment of CEET.]]></description>
<pubDate>2022/3/29 14:34:19</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Li-Juan Huang, Yu-Yu Wu and Ning-Dong Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Juan Huang, Yu-Yu Wu and Ning-Dong Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220421]]></guid><cfi:id>15</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A survey of anaesthetic preferences in cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220222]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify current trends in anaesthesia technique for cataract surgery and make this information available to ophthalmologists.METHODS: An electronic survey was created and distributed to members of online ophthalmology forums; results were subsequently analysed in spreadsheet software.RESULTS: In total there were 71 completed surveys. The most preferred anaesthesia technique in cataract cases was topical anaesthesia with intracameral injection (n=34, 47.9%), and the least preferred techniques were retrobulbar (n=1, 1.4%) and peribulbar blocks (n=1, 1.4%). The most commonly preferred local anaesthetic was lidocaine 2% (n=41, 57.7%).CONCLUSION: Topical anaesthesia techniques with lidocaine 2% appear to be the most preferred method of anaesthesia in cataract surgery in our survey. Compared with previous literature our survey shows that topical anaesthesia is being increasingly used in cataract surgery, especially in conjunction with intracameral injection. The predominant reasons for this seem to be patient comfort and ease of technique.]]></description>
<pubDate>2022/1/26 9:59:41</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Moaz Hamid, Haaris A. Shiwani and Faraz Hamid]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Moaz Hamid, Haaris A. Shiwani and Faraz Hamid</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220222]]></guid><cfi:id>14</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Should mitral valve prolapse be considered as one of the risk factors for open angle glaucoma? A preliminary observation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220223]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the incidence of mitral valve prolapse in patients with newly diagnosed primary open angle glaucoma.METHODS: The study included 12 patients without any other comorbidities or taking any general or local medications. Each patient underwent a full ophthalmological examination with visual field assessment and optical computed tomography of the macula and optic nerve head. Carotid Doppler ultrasound was performed to exclude impaired blood flow in this region and transthoracic echocardiography with assessment of the function and morphology of the heart valves.RESULTS: In the study group, mitral valve prolapse was found in seven patients (58.3%), while mitral valve regurgitation in 11 patients (91.7%). One case of normal pressure glaucoma and four cases of juvenile glaucoma were diagnosed. There were also other risk factors for glaucoma: myopia (58.3%), migraine headaches (41.7%), a positive family history of glaucoma (16.7%).CONCLUSION: Mitral valve prolapse could be indicated as a new risk factor for glaucoma. It seems reasonable to conduct screening tests for glaucoma in patients with mitral valve prolapse in the course of echocardiography.]]></description>
<pubDate>2022/1/26 9:59:41</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ewa Grudzińska, Malgorzata Peregud-Pogorzelska, Daniel Zaborski and Monika Modrzejewska]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ewa Grudzińska, Malgorzata Peregud-Pogorzelska, Daniel Zaborski and Monika Modrzejewska</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220223]]></guid><cfi:id>13</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Amblyopia screening for first and second-grade children in Jordan]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220224]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To share the results of a national screening program for amblyopia in school children in the north of Jordan.METHODS: This is a prospective national screening study for amblyopia. The program rolls first and second-grade children (6 to 7 years old) in the north of Jordan. The eye examination included: best-corrected visual acuity, cover-uncover test, and cycloplegic retinoscopy. Monocular visual acuity was tested using an ETDRS visual acuity chart without correction. Moreover, children were tested with full cycloplegic refraction when the test criteria were met. Unilateral amblyopia was defined as a best-corrected visual acuity difference of 2 or more lines. In comparison, bilateral amblyopia was defined as a best-corrected visual acuity of 20/40 or worse in the best eye.RESULTS: The prevalence of amblyopia for the total sample tested (n=17 203) was 2.78% (n=479). The most common cause of amblyopia was hypermetropia (64.45%), followed by previous ocular surgeries (15.1%), myopia (10.43%), strabismus (9.39%), and congenital cataract (0.63%).CONCLUSION: This is the first and only study, identiﬁng modifiable risk factors in Jordanian children with amblyopia. In their first couple of years of elementary education, many Jordanian children are affected by amblyopia and pass unnoticed. A more governmental effort is needed into screening programs to improve vision in the Jordanian population.]]></description>
<pubDate>2022/1/26 9:59:41</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Khalil M. Al-Salem, Mohammad S. Saleem, Ismat Ereifej, Hamzeh M. Alrawashdeh, Rayed Falah Hussein Obeidat, Asma Ali Abdlmohdi, Raeda Zaki Al-Momani, Layal Mohammed Hammad, Omar Ahmad al-Habahbeh, Yaqeen M. Assassfeh, Laith Ramzi Najib Al-Qsous, Ashraf Hatim Adeeb Nasraween, Tariq A. AlMaaitah, Deya'-Aldin Muneer Hasan Aqeel, Ibtehal Eyadeh Awad Alabdulrazzg, Abdullah Mahmoud Mohammad Murad, Amany Jehad Faleh AL-Zurqan, Enas Jamal Mohammad Jaradat, Slsabela Emad Suliman Aldhoon, Ala'a Majed Dmour, Ahmad Talal Asassfeh, Jeries Ayman Halaseh, Abdel Aziz Ammar Daoud, Waha Ayman Alkasasbeh and Kholoud GH. Matar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Khalil M. Al-Salem, Mohammad S. Saleem, Ismat Ereifej, Hamzeh M. Alrawashdeh, Rayed Falah Hussein Obeidat, Asma Ali Abdlmohdi, Raeda Zaki Al-Momani, Layal Mohammed Hammad, Omar Ahmad al-Habahbeh, Yaqeen M. Assassfeh, Laith Ramzi Najib Al-Qsous, Ashraf Hatim Adeeb Nasraween, Tariq A. AlMaaitah, Deya'-Aldin Muneer Hasan Aqeel, Ibtehal Eyadeh Awad Alabdulrazzg, Abdullah Mahmoud Mohammad Murad, Amany Jehad Faleh AL-Zurqan, Enas Jamal Mohammad Jaradat, Slsabela Emad Suliman Aldhoon, Ala'a Majed Dmour, Ahmad Talal Asassfeh, Jeries Ayman Halaseh, Abdel Aziz Ammar Daoud, Waha Ayman Alkasasbeh and Kholoud GH. Matar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220224]]></guid><cfi:id>12</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A simple technique for suprachoroidal space injection of triamcinolone acetonide in treatment of macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221218]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce a simple resistance controlled suprachoroidal space (SCS) injection technique using a disposable 30-gauge needle connected to a 1 mL syringe and evaluate the effectiveness and applicability of this technique in the treatment of macular edema.METHODS: A total of 20 patients with various types of macular edema were subjected to a resistance controlled SCS injection of triamcinolone acetonide (TA) with a disposable 30-gauge needle connected to a 1 mL syringe. This technique allows the easy and smooth injection of the TA only once the tip of the needle reached the potential SCS which was indicated by the lower resistance on the plunger. The main outcome measures were anterior segment spectral-domain optical coherence tomography (AS-OCT) measurements post-operation immediately and central subfield thickness (CST), best-corrected visual acuity (BCVA), and intraocular pressure (IOP) measurements at 3mo post-operation.RESULTS: AS-OCT examination showed the expansion of the SCS near the injection site immediately after SCS injection. At three months of follow-up, as compared to the baseline, the mean CST was significantly decreased from 535.0±157.24 to 319.55±127.30 μm (P < 0.001), the mean BCVA was significantly improved from 1.05±0.41 to 0.73±0.41 logMAR (P<0.001), and the mean IOP was not significantly different, from 15.05 ± 2.54  to 15.85 ± 3.60 mm Hg (P=0.185). Any complication related to the injection procedure including cataract, choroidal and retinal hemorrhage, retinal detachment, or endophthalmitis was not observed in this study.CONCLUSION: The simple and minimally invasive technique of SCS injection of TA with a disposable 30-gauge needle connected to a 1 mL syringe is useful and applicable for macular edema.]]></description>
<pubDate>2022/11/22 10:48:20</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Dan-Dan Zhang, Dan-Yang Che and Dong-Qing Zhu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan-Dan Zhang, Dan-Yang Che and Dong-Qing Zhu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221218]]></guid><cfi:id>11</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of intraocular pressure readings with Perkins, Tonopen, iCare 200, and iCare Home to manometry in cadaveric eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221219]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare intraocular pressure (IOP) readings obtained with Perkins tonometry, iCare Home, iCare 200, and Tonopen to IOP readings obtained with the manometer of a perfusion system to assess the accuracy and reproducibility of each method of tonometry at set pressures.METHODS: The IOP of human cadaveric eyes (n=2) was measured using a manometer inserted into the eye through the optic nerve. IOP measurements were obtained using a Perkins tonometer, iCare Home, iCare 200, and Tonopen. These measurements were compared to set point IOP measurements of a manometer to determine accuracy and reproducibility of each device.RESULTS: Mean IOP readings obtained with the Perkins tonometer compared to manometer readings demonstrated a difference of -1.0±5.0 mm Hg (P=0.45), indicating a lower reading on average than manometery although not significant. Mean IOP difference between iCare 200 and manometer was 5.3±2.2 mm Hg (P<0.0001). Mean difference in IOP between iCare Home and manometer was 3.5±2.4 mm Hg (P=0.0004). Mean IOP difference compared to manometer was 4.6±4.0 mm Hg for the Tonopen (P<0.0001). IOP measurements obtained with the Perkins tonometer demonstrated a standard deviation of 5.0 mm Hg while the Tonopen measurements demonstrated a 4.0 mm Hg standard deviation. In comparison, iCare 200 and iCare Home demonstrated 2.2 and 2.4 mm Hg standard deviation, respectively.CONCLUSION: Applanation tonometry produces more accurate IOP readings than rebound tonometry or Tonopen, however it demonstrates greater variability than the other forms of tonometry. Rebound tonometry is more reproducible but tends to over-estimate IOP.]]></description>
<pubDate>2022/11/22 10:48:20</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Monica K Ertel, Leonard K Seibold, Jennifer L Patnaik and Malik Y Kahook]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Monica K Ertel, Leonard K Seibold, Jennifer L Patnaik and Malik Y Kahook</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221219]]></guid><cfi:id>10</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes after combined excisional goniotomy and manual small incision cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the long-term outcomes of combined excisional goniotomy and manual small incision cataract surgery (MSICS).METHODS: This is a retrospective case series of patients with open angle glaucoma and visually significant cataracts that underwent combined excisional goniotomy and MSICS with one-year follow-up. The medical history, demographic information, and clinical characteristics of each case were recorded. Data regarding changes in vision, intraocular pressure (IOP), the number of glaucoma medications, and the evolution of the disease after surgery were reported.RESULTS: Three patients, with open angle glaucoma and cataracts underwent combined excisional goniotomy and MSICS without adverse events. All patients had improvement in vision compared to baseline measurements. The range of IOP at baseline was from 14 to 18 mm Hg and decrease to a range of 10 to 14 mm Hg after one year of follow-up. Additionally, two patients also decreased their dependence on IOP-lowering medications at the last follow up visit with one patient maintaining baseline level of medication use.CONCLUSION: A combination of excisional goniotomy and MSICS illustrates both the safety and efficacy to treat patients with visually significant cataract and glaucoma. This procedure allows for a more cost-effective surgical approach that matches the needs of resource strained territories around the globe.]]></description>
<pubDate>2022/9/21 16:28:50</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Daniela Alvarez-Ascencio, Gabriel Lazcano-Gomez and Malik Y Kahook]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Daniela Alvarez-Ascencio, Gabriel Lazcano-Gomez and Malik Y Kahook</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221021]]></guid><cfi:id>9</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Simultaneous tectonic Descemet stripping endothelial keratoplasty and tectonic Bowman layer transplant for the management of corneal perforation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230924]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the outcomes of three cases of corneal perforation managed with simultaneous tectonic Descemet stripping endothelial keratoplasty (t-DSEK) and tectonic Bowman layer transplant (t-BLT) as an alternative to tectonic penetrating keratoplasty (t-PKP).METHODS: Three eyes of three patients receiving simultaneous t-DSEK and t-BLT for corneal perforation were included. The technique for DSEK was modified depending on individual requirements. The t-BLT technique was standardised using an 8 mm graft and fixated with a running suture. Success was measured by the ability of this procedure to close a corneal perforation.RESULTS: All three cases achieved tectonic eye globe restoration and remained stable during the minimum 3-month observation period. Reinterventions were relatively common: 2 cases required amniotic membrane transplant for persistent epithelial defects. One case required DSEK rebubbling. One case developed angle closure glaucoma requiring surgical peripheral iridectomy.CONCLUSION: Simultaneous t-DSEK and t-BLT may be a useful strategy for the management of corneal perforation as an alternative management to t-PKP for selected cases.]]></description>
<pubDate>2023/8/22 11:33:45</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Abdo Karim Tourkmani, Colm McAlinden, David F. Anderson, Jorge L. Alio del Barrio, Jorge L. Alió]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdo Karim Tourkmani, Colm McAlinden, David F. Anderson, Jorge L. Alio del Barrio, Jorge L. Alió</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230924]]></guid><cfi:id>8</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Recording the direct surgeon’s view with an operating microscopic view improves microscopic ophthalmic surgery training]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230925]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To establish a recording system with a direct view of the surgeon to supplement video recording under an operating microscope, which lacks information on the movement and position of the surgeon's hands, and to facilitate the reproduction of a skilled surgeon's technique by a surgeon in training.METHODS: A small camera was attached to the operating microscope with a custom adapter. Microscopic surgeon's view and direct surgeon's view through this new camera were recorded in the surgical recording system. Both movies were synchronized and analyzed how do surgeons handle the instruments.RESULTS: A small camera attached to the operating microscope allowed the surgeon's hands motion to be recorded without interfering with the surgeon's movements. Different surgeons used different methods to manipulate the ultrasound handpiece and the irrigation/aspiration device. Even in the simple paracentesis procedure, different surgeons used different methods. Surgeons-in-training were able to identify and improve their weaknesses by watching synchronized movies of their hand motions and microscopic view.CONCLUSION: Simultaneous recording the surgical field out of the operating microscopic view by a small camera set on the microscope is comprehensive and improves surgeons-in-training understanding and learning surgeries.]]></description>
<pubDate>2023/8/22 11:33:45</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Masayuki Akimoto, Kosei Tomita, Miyo Yoshida, Yuki Hama]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Masayuki Akimoto, Kosei Tomita, Miyo Yoshida, Yuki Hama</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230925]]></guid><cfi:id>7</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diffusion tensor imaging of horizontal extraocular muscles in patients with concomitant and paralytic esotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230822]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess metrics of diffusion tensor imagining (DTI) in evaluating microstructural abnormalities of horizontal extraocular muscles (EOM) in esotropia.METHODS: Six adult concomitant esotropia patients, 5 unilateral abducent paralysis patients and 2 healthy volunteers were enrolled. Conventional magnetic resonance imaging (MRI) and DTI were performed on all subjects using 3T MR scanner. Fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) of medial and lateral rectus muscles were measured and compared between patients group and control group.RESULTS: Medial rectus MD and RD within the adducted eye of concomitant patients was significantly greater than that in unilateral abducent paralysis patients (0.259×10-2 mm2/s vs 0.207×10-2 mm2/s, P=0.014; 0.182×10-2 mm2/s vs 0.152×10-2 mm2/s, P=0.017). Both strabismus patients showed a significantly decreased MD and AD than that obtained in normal controls for lateral rectus muscles (P<0.05). Medial rectus MD of the adducted eye in concomitant strabismus patients was significantly decreased than that in healthy controls (0.259×10-2 mm2/s vs 0.266×10-2 mm2/s, P=0.010). Lateral rectus AD of the adducted eye in concomitant strabismus patients was significantly decreased as compared with that in healthy controls (0.515×10-2 mm2/s vs 0.593×10-2 mm2/s, P=0.013). No statistically significant differences were present between the adducted and fixating eyes in concomitant strabismus patients.CONCLUSION: DTI represents a feasible technique to assess tissue characteristics of EOM. The effects of eye position changes on DTI parameters are subtle. Decreased MD and RD could be evidence for remodeling of the medial rectus muscle contracture. Lower medial and lateral recuts MD of concomitant esotropia patients indicates a thinner fibrous structure of the EOM. Lower MD and AD should be general character of esotropia.]]></description>
<pubDate>2023/7/25 10:38:18</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Ming-Hao Chen and Jian-Hua Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ming-Hao Chen and Jian-Hua Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230822]]></guid><cfi:id>6</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[“Capsule drape wrap”—a new technology for iridoschisis management during phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230623]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce a new technique for iridoschisis management during phacoemulsification: “capsule drape wrap”.METHODS: “Capsule drape wrap” technique was used for an 80-year-old man with idiopathic iridoschisis in the right eye during phacoemulsification. The inserted flexible nylon iris hooks to hold anterior capsule in place, the margin of the anterior capsule could act as drape wrap, tracking the fibrillary iris strands firmly from free floating and stabilizing the capsular bags simultaneously.RESULTS: The eye with iridoschisis was successfully treated. Iris fibrils remained immobile during the procedure, and despite the severity of iridoschisis, there were no intraoperative complications such as tear of the iris, hyphema, iris prolapse, loss of mydriasis, or rupture of the posterior lens capsule during phacoemulsification. The best-corrected visual acuity was increased by 0.1 (logMAR) 6mo after the surgery.CONCLUSION: “Capsule drape wrap” for iridoschisis is easily manageable, prevents further disruption to the loose iris fibers and ensures the stability of capsule–iris complex simultaneously, consequently minimizing the risk of surgical complications in phacoemulsification.]]></description>
<pubDate>2023/5/30 14:30:35</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Hui Chen, Wan Chen, Yong-Bin Lin and Wei-Rong Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Chen, Wan Chen, Yong-Bin Lin and Wei-Rong Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230623]]></guid><cfi:id>5</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined aqueous misdirection and persistent choroidal effusions following implantation of a Preserflo MicroShunt]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230421]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe a case of aqueous misdirection complicated by subsequent persistent choroidal effusions following implantation of a Preserflo MicroShunt (PMS) device to treat advanced closed angle glaucoma.METHODS: A 67-year-old caucasian female with advanced primary angle-closure glaucoma on four medications with an intraocular pressure (IOP) of 26 mm Hg was listed for a PMS insertion with mitomycin C (MMC).RESULTS: Past ocular history was significant for pseudophakia and previous yttrium aluminum garnet (YAG) peripheral iridotomy. Surgery was uneventful but on the first postoperative day, she developed aqueous misdirection complicated by subsequent development of persistent uveal effusions. Conventional treatment strategies including atropine drops, YAG hyaloidotomy and choroidal effusion drainage proved ineffective. A combination of oral steroids and pars plana vitrectomy (PPV) along with an irido-zonulo-hyloidectomy (IZH) proved efficacious.CONCLUSION: To the best of the author’s knowledge, this is the first published case of aqueous misdirection complicated with the presence of significant, unresolving choroidal effusions, highlighting the possibility and sequelae of comorbid pathology in nanophthalmic eyes.]]></description>
<pubDate>2023/3/30 16:20:49</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Huzaifa Malick, Craig Wilde and Richard E Stead]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Huzaifa Malick, Craig Wilde and Richard E Stead</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230421]]></guid><cfi:id>4</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Small incision lenticule extraction and femtosecond-assisted laser in situ keratomileusis in patients with deep corneal opacity: case series]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230219]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the safety, efficacy, and accuracy of small-incision lenticule extraction (SMILE) or femtosecond-assisted laser in situ keratomileusis (FS-LASIK) for the correction of myopia or myopic astigmatism in patients with deep corneal opacity denoted by anterior segment optical coherence tomography (AS-OCT).METHODS: Four patients with monocular corneal opacity (3 due to mechanical injury, 1 due to a firecracker wound) were recruited and treated with refractive surgery (3 for SMILE, 1 for FS-LASIK combined with limbal relaxing incision (LRI). Preoperative ocular manifestations, surgical details, postoperative visual outcomes, corneal opacity parameters, and corneal topography were analyzed.RESULTS: Preoperatively, spherical diopter ranged from -3.0 D to -4.75 D with cylinder ranging from -0.75 to -5.0 D, and corrected distance visual acuity (CDVA) ranging from 20/25 to 20/20. One eye’s corneal opacity was located in the central zone and three were in the mid-peripheral optical zone. Three patients underwent uneventful SMILE in both eyes, whilst one patient underwent FS-LASIK for high astigmatism in both eyes and LRI in the right eye. CDVA of the eye with corneal opacity ranged from 20/22 to 20/20 one to six weeks postoperatively. Two patients achieved better CDVA and no patients lost Snellen lines. The postoperative diopter was within ±0.75 D for all eyes. Significant edema existed above the corneal opacity in one eye and dissipated soon. No eccentric corneal topography or morphological anomaly of the corneal cap or flap was observed.CONCLUSION: The cases demonstrate that SMILE or FS-LASIK is safe and effective to treat myopic astigmatism combined with deep corneal opacity lesions after comprehensive preoperative evaluation and appropriate candidate selection. FS-LASIK combined with LRI is also sufficient for correcting high astigmatism due to corneal scarring.]]></description>
<pubDate>2023/2/2 15:59:18</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Zhi Fang, Xiao-Ying He and Wei Han]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi Fang, Xiao-Ying He and Wei Han</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230219]]></guid><cfi:id>3</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features of retinal amyloid angiopathy with transthyretin Gly83Arg variant]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230119]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report on the clinical features of patients with retinal amyloid angiopathy (RAA) who were identified to be caused by the transthyretin (TTR) Gly83Arg variant.METHODS: Case series of five patients diagnosed with RAA was collected at Affiliated Hospital of Zunyi Medical University from January 2010 to December 2021. The clinical features, therapeutic strategies, and prognoses of all patients were reviewed.RESULTS: Five patients with a mean age of 52.00±7.23y were diagnosed as RAA. These patients were previously diagnosed with hereditary transthyretin amyloidosis caused by the TTR Gly83Arg variant. Vitreous opacity was found in all 10 eyes, and 7 eyes developed RAA 2 to 20y after the onset of hereditary transthyretin amyloidosis. The clinical manifestations were recurrent vitreous hemorrhage in 2 eyes (29%), neovascular glaucoma in 2 eyes (29%), and iris neovascularization in 1 eye (14%). Microangioma lesions were found in all affected eyes that underwent fundus fluorescein angiography (FFA) in this group of cases, and the incidence of the retinal non-perfusion area was 67%. Although no cases of retinal neovascularization were found, the prognosis of visual acuity was not ideal.CONCLUSION: This is the first report of RAA in patients with the TTR Gly83Arg variant. Complications such as RAA and glaucoma will seriously affect the visual prognosis of patients. Thereafter, regular ophthalmic follow-up of patients with hereditary transthyretin amyloidosis is essential. And FFA after vitrectomy is very important, which can help ophthalmologists detect RAA earlier and treat it in time.]]></description>
<pubDate>2022/12/23 15:16:45</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Gang Su, Xing-Wang Chen, Jun-Lin Pan, Hong Li, Bing Xie and Shan-Jun Cai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gang Su, Xing-Wang Chen, Jun-Lin Pan, Hong Li, Bing Xie and Shan-Jun Cai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230119]]></guid><cfi:id>2</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Axial length shortening in myopic children with Stickler syndrome after repeated low-level red-light therapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231022]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the myopia-controlling effect of repeated low-level red-light (RLRL) therapy in patients with Stickler syndrome (STL), an inherited collagenic disease typically presenting with early onset myopia.METHODS: Three STL children, aged 3, 7, and 11y, received RLRL therapy throughout the follow-up period of 17, 3, and 6mo, respectively after exclusion of fundus anomalies. Data on best-corrected visual acuity (BCVA), intraocular pressure, cycloplegic subjective refraction, ocular biometrics, scanning laser ophthalmoscope, optical coherence tomography, genetic testing, systemic disease history, and family history were recorded.RESULTS: At the initiation of the RLRL therapy, the spherical equivalent (SE) of 6 eyes from 3 patients ranged from -3.75 to -20.38 D, axial length (AL) were from 23.88 to 30.68 mm, and BCVA were from 0.4 to 1.0 (decimal notation). Myopia progression of all six eyes slowed down after RLRL therapy. AL in five out of the six eyes shortened -0.07 to -0.63 mm. No side effects were observed.CONCLUSION: Three cases of STL whose progression of myopic shift and AL elongation are successfully reduced and even reversed after RLRL therapy.]]></description>
<pubDate>2023/9/19 15:49:15</pubDate>
<category><![CDATA[Brief Report]]></category>
<author><![CDATA[Xiang-Hua Tang, Meng-Ting Yu, Yin Hu, Ming-Guang He, Xiao Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiang-Hua Tang, Meng-Ting Yu, Yin Hu, Ming-Guang He, Xiao Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231022]]></guid><cfi:id>1</cfi:id><cfi:read>true</cfi:read></item>
</channel>
</rss>